Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jonathan Epstein

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Anatomy

Chemicals & Drugs

Concepts & Ideas

Physiology

Disease Progression

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Miyamoto Hiroshi; Hernandez David J; Epstein Jonathan I
A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.
Duffield Amy S; Lee Thomas K; Miyamoto Hiroshi; Carter H Ballantine; Epstein Jonathan I
Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails.
Albadine Roula; Latour Mathieu; Toubaji Antoun; Haffner Michael; Isaacs William B; A Platz Elizabeth; Meeker Alan K; Demarzo Angelo M; Epstein Jonathan I; Netto George J
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jonathan Epstein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Miyamoto Hiroshi; Hernandez David J; Epstein Jonathan I
A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.
Human pathology 2009;40(12):1693-8.
2009: Duffield Amy S; Lee Thomas K; Miyamoto Hiroshi; Carter H Ballantine; Epstein Jonathan I
Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails.
The Journal of urology 2009;182(5):2274-8.
2009: Albadine Roula; Latour Mathieu; Toubaji Antoun; Haffner Michael; Isaacs William B; A Platz Elizabeth; Meeker Alan K; Demarzo Angelo M; Epstein Jonathan I; Netto George J
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(11):1415-22.
2009: Trock Bruce J; Guo Charles C; Gonzalgo Mark L; Magheli Ahmed; Loeb Stacy; Epstein Jonathan I
Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.
The Journal of urology 2009;182(4):1364-70.
2009: Tavora Fabio; Epstein Jonathan I
Urothelial carcinoma with abundant myxoid stroma.
Human pathology 2009;40(10):1391-8.
2009: Montgomery Elizabeth; Epstein Jonathan I
Anastomosing hemangioma of the genitourinary tract: a lesion mimicking angiosarcoma.
The American journal of surgical pathology 2009;33(9):1364-9.
2009: Miller Jeremy S; Lee Thomas K; Epstein Jonathan I; Ulbright Thomas M
The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases.
The American journal of surgical pathology 2009;33(9):1293-8.
2009: Albadine Roula; Wang Wenle; Brownlee Noel A; Toubaji Antoun; Billis Athanase; Argani Perdram; Epstein Jonathan I; Garvin A Julian; Cousi Rima; Schaeffer Edward M; Pavlovich Christian; Netto George J
Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy.
The Journal of urology 2009;182(2):735-40.
2009: Miller Jeremy S; Epstein Jonathan I
Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases.
The American journal of surgical pathology 2009;33(8):1241-8.
2009: Isharwal Sumit; Miller M Craig; Epstein Jonathan I; Mangold Leslie A; Humphreys Elizabeth; Partin Alan W; Veltri Robert W
DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.
Urology 2009;73(5):1092-7.
2009: Higgins John P; McKenney Jesse K; Brooks James D; Argani Pedram; Epstein Jonathan I;
Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology.
Human pathology 2009;40(4):456-63.
2009: Kramer Barnett S; Hagerty Karen L; Justman Stewart; Somerfield Mark R; Albertsen Peter C; Blot William J; Carter H Ballentine; Costantino Joseph P; Epstein Jonathan I; Godley Paul A; Harris Russell P; Wilt Timothy J; Wittes Janet; Zon Robin; Schellhammer Paul;
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
The Journal of urology 2009;181(4):1642-57.
2009: Lotan Tamara L; Epstein Jonathan I
Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy.
Human pathology 2009;40(4):471-7.
2009: Zhao Jin; Epstein Jonathan I
High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
The American journal of surgical pathology 2009;33(4):583-90.
2009: Kramer Barnett S; Hagerty Karen L; Justman Stewart; Somerfield Mark R; Albertsen Peter C; Blot William J; Ballentine Carter H; Costantino Joseph P; Epstein Jonathan I; Godley Paul A; Harris Russell P; Wilt Timothy J; Wittes Janet; Zon Robin; Schellhammer Paul;
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(9):1502-16.
2009: Lotan Tamara L; Toubaji Antoun; Albadine Roula; Latour Mathieu; Herawi Mehsati; Meeker Alan K; DeMarzo Angelo M; Platz Elizabeth A; Epstein Jonathan I; Netto George J
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(3):359-65.
2009: Amin Mahul B; Gupta Ruta; Ondrej Hes; McKenney Jesse K; Michal Michal; Young Andrew N; Paner Gladell P; Junker Kerstin; Epstein Jonathan I
Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm.
The American journal of surgical pathology 2009;33(3):393-400.
2009: Ye Huihui; Yoon Ghil Suk; Epstein Jonathan I
Intrarenal ectopic adrenal tissue and renal-adrenal fusion: a report of nine cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(2):175-81.
2009: Epstein Jonathan I
Precursor lesions to prostatic adenocarcinoma.
Virchows Archiv : an international journal of pathology 2009;454(1):1-16.
2009: Duffield Amy S; Epstein Jonathan I
Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the initial review of slides.
The American journal of surgical pathology 2009;33(1):120-5.
2008: Ali Tehmina Z; Epstein Jonathan I
False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
The American journal of surgical pathology 2008;32(12):1890-5.
2008: Isharwal Sumit; Miller Michael Craig; Epstein Jonathan I; Mangold Leslie A; Humphreys Elizabeth; Partin Alan W; Veltri Robert W
Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomy.
International journal of cancer. Journal international du cancer 2008;123(11):2636-43.
2008: Veltri Robert W; Isharwal Sumit; Miller M Craig; Epstein Jonathan I; Mangold Leslie A; Humphreys Elizabeth; Partin Alan W
Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.
The Prostate 2008;68(16):1806-15.
2008: Tavora Fabio; Epstein Jonathan I
Bladder cancer, pathological classification and staging.
BJU international 2008;102(9 Pt B):1216-20.
2008: Netto Georges J; Nakai Yasutomo; Nakayama Masashi; Jadallah Sana; Toubaji Antoun; Nonomura Norio; Albadine Roula; Hicks Jessica L; Epstein Jonathan I; Yegnasubramanian Srinivasan; Nelson William G; De Marzo Angelo M
Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(11):1337-44.
2008: Latour Mathieu; Amin Mahul B; Billis Athanase; Egevad Lars; Grignon David J; Humphrey Peter A; Reuter Victor E; Sakr Wael A; Srigley John R; Wheeler Thomas M; Yang Ximing J; Epstein Jonathan I
Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology.
The American journal of surgical pathology 2008;32(10):1532-9.
2008: Evans Andrew J; Henry Pauline C; Van der Kwast Theodorus H; Tkachuk Douglas C; Watson Kemp; Lockwood Gina A; Fleshner Neil E; Cheung Carol; Belanger Eric C; Amin Mahul B; Boccon-Gibod Liliane; Bostwick David G; Egevad Lars; Epstein Jonathan I; Grignon David J; Jones Edward C; Montironi Rodolfo; Moussa Madeleine; Sweet Joan M; Trpkov Kiril; Wheeler Thomas M; Srigley John R
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens.
The American journal of surgical pathology 2008;32(10):1503-12.
2008: Samaratunga Hemamali; Epstein Jonathan I
What is the molecular pathology of low-risk prostate cancer?
World journal of urology 2008;26(5):431-6.
2008: Burchardt M; Engers R; Müller M; Burchardt T; Willers R; Epstein J I; Ackermann R; Gabbert H E; de la Taille A; Rubin M A
Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays.
Journal of cancer research and clinical oncology 2008;134(10):1071-8.
2008: Lane Zhaoli; Hansel Donna E; Epstein Jonathan I
Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
The American journal of surgical pathology 2008;32(9):1322-6.
2008: Lotan Tamara L; Epstein Jonathan I
Diffuse adenosis of the peripheral zone in prostate needle biopsy and prostatectomy specimens.
The American journal of surgical pathology 2008;32(9):1360-6.
2008: Osunkoya Adeboye O; Carter H Ballentine; Epstein Jonathan I
A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.
Urology 2008;72(3):638-40.
2008: Osunkoya Adeboye O; Hansel Donna E; Parwani Anil V; Ali Tehmina Z; Tamas Ecaterina F; Untawale Vasundhara G; Kahane Hillel; Epstein Jonathan I
The Symphony protocol for H&E staining of prostatic adenocarcinoma on needle biopsy: a multicentre analysis of 120 cases.
Pathology 2008;40(5):450-6.
2008: Chuang Ai-Ying; Epstein Jonathan I
Positive surgical margins in areas of capsular incision in otherwise organ-confined disease at radical prostatectomy: histologic features and pitfalls.
The American journal of surgical pathology 2008;32(8):1201-6.
2008: Tavora Fabio; Montgomery Elizabeth; Epstein Jonathan I
A series of vascular tumors and tumorlike lesions of the bladder.
The American journal of surgical pathology 2008;32(8):1213-9.
2008: Tavora Fabio; Epstein Jonathan I
High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
The American journal of surgical pathology 2008;32(7):1060-7.
2008: Osunkoya Adeboye O; Adsay N Volkan; Cohen Cynthia; Epstein Jonathan I; Smith Stacey L
MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(7):789-94.
2008: Paner Gladell P; McKenney Jesse K; Epstein Jonathan I; Amin Mahul B
Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
The American journal of surgical pathology 2008;32(7):1022-8.
2008: Hernandez David J; Nielsen Matthew E; Han Misop; Trock Bruce J; Partin Alan W; Walsh Patrick C; Epstein Jonathan I
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy.
Urology 2008;72(1):172-6.
2008: Wehle Danielle; Yonescu Raluca; Long Patricia P; Gala Nalini; Epstein Jonathan; Griffin Constance A
Fluorescence in situ hybridization of 12p in germ cell tumors using a bacterial artificial chromosome clone 12p probe on paraffin-embedded tissue: clinical test validation.
Cancer genetics and cytogenetics 2008;183(2):99-104.
2008: Wang Wenle; Montgomery Elizabeth; Epstein Jonathan I
Benign nerve sheath tumors on urinary bladder biopsy.
The American journal of surgical pathology 2008;32(6):907-12.
2008: Yoon Ghil Suk; Wang Wenle; Osunkoya Adeboye O; Lane Zhaoli; Partin Alan W; Epstein Jonathan I
Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma.
The Journal of urology 2008;179(6):2203-6; discussion 2206.
2008: Wang Wenle; Sun Xinlai; Epstein Jonathan I
Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
The American journal of surgical pathology 2008;32(6):851-7.
2008: Epstein Jonathan I
Does tertiary Gleason score 5 have prognostic significance in men with prostate cancer?
Nature clinical practice. Urology 2008;5(5):250-1.
2008: Lane Zhaoli; Epstein Jonathan I
Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
The American journal of surgical pathology 2008;32(5):758-64.
2008: Epstein Jonathan I
Is radical prostatectomy tumor volume an independent predictor of prognosis in men with favorable preoperative clinical and pathologic findings.
Urology 2008;71(5):985.
2008: Fine Samson W; Epstein Jonathan I
A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
The Journal of urology 2008;179(4):1335-8; discussion 1338-9.
2008: Lane Zhaoli; Epstein Jonathan I; Ayub Salman; Netto George J
Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
Human pathology 2008;39(4):543-9.
2008: Fine Jeffrey L; Grzybicki Dana M; Silowash Russell; Ho Jonhan; Gilbertson John R; Anthony Leslie; Wilson Robb; Parwani Anil V; Bastacky Sheldon I; Epstein Jonathan I; Jukic Drazen M
Evaluation of whole slide image immunohistochemistry interpretation in challenging prostate needle biopsies.
Human pathology 2008;39(4):564-72.
2008: Müntener Michael; Epstein Jonathan I; Hernandez David J; Gonzalgo Mark L; Mangold Leslie; Humphreys Elizabeth; Walsh Patrick C; Partin Alan W; Nielsen Matthew E
Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy.
European urology 2008;53(4):767-75; discussion 775-6.
2008: Osunkoya Adeboye O; Hansel Donna E; Sun Xinlai; Netto George J; Epstein Jonathan I
Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
The American journal of surgical pathology 2008;32(3):461-7.
2008: Osunkoya Adeboye O; Nielsen Matthew E; Epstein Jonathan I
Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases.
The American journal of surgical pathology 2008;32(3):468-72.
2008: Sheridan Todd B; Carter H Ballentine; Wang Wenle; Landis Patricia B; Epstein Jonathan I
Change in prostate cancer grade over time in men followed expectantly for stage T1c disease.
The Journal of urology 2008;179(3):901-4; discussion 904-5.
2008: Epstein Jonathan I
Radial distance of extraprostatic extension measured by an ocular micrometer is an independent predictor of prostate-specific antigen recurrence: a new proposal for the substaging of pT3a prostate cancer.
The American journal of surgical pathology 2008;32(2):337-8; author reply 338-40.
2008: Makarov Danil V; Marlow Cameron; Epstein Jonathan I; Miller M Craig; Landis Patricia; Partin Alan W; Carter H Ballentine; Veltri Robert W
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent.
The Prostate 2008;68(2):183-9.
2008: Lane Zhaoli; Epstein Jonathan I
Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy.
The American journal of surgical pathology 2008;32(1):92-7.
2008: Wang Wenle; Epstein Jonathan I
Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
The American journal of surgical pathology 2008;32(1):65-71.
2008: Epstein Jonathan I; Srigley John; Grignon David; Humphrey Peter;
Recommendations for the reporting of prostate carcinoma: Association of Directors of Anatomic and Surgical Pathology.
American journal of clinical pathology 2008;129(1):24-30.
2007: Carter H Ballentine; Kettermann Anna; Warlick Christopher; Metter E Jeffrey; Landis Patricia; Walsh Patrick C; Epstein Jonathan I
Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.
The Journal of urology 2007;178(6):2359-64; discussion 2364-5.
2007: Osunkoya Adeboye O; Netto George J; Epstein Jonathan I
Colorectal adenocarcinoma involving the prostate: report of 9 cases.
Human pathology 2007;38(12):1836-41.
2007: Kleeberger Wolfram; Bova G Steven; Nielsen Matthew E; Herawi Mehsati; Chuang Ai-Ying; Epstein Jonathan I; Berman David M
Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis.
Cancer research 2007;67(19):9199-206.
2007: Hansel Donna E; Epstein Jonathan I; Berbescu Ema; Fine Samson W; Young Robert H; Cheville John C
Renal carcinoid tumor: a clinicopathologic study of 21 cases.
The American journal of surgical pathology 2007;31(10):1539-44.
2007: Chuang Ai-Ying; Nielsen Matthew E; Hernandez David J; Walsh Patrick C; Epstein Jonathan I
The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1306-10.
2007: Magheli Ahmed; Rais-Bahrami Soroush; Carter H Ballentine; Peck Hugh J; Epstein Jonathan I; Gonzalgo Mark L
Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1277-80; discussion 1280-1.
2007: Magheli Ahmed; Rais-Bahrami Soroush; Peck Hugh J; Walsh Patrick C; Epstein Jonathan I; Trock Bruce J; Gonzalgo Mark L
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
The Journal of urology 2007;178(4 Pt 1):1311-5.
2007: Epstein Jonathan I; Srigley John; Grignon David; Humphrey Peter; Otis Christopher
Recommendations for the reporting of prostate carcinoma.
Virchows Archiv : an international journal of pathology 2007;451(4):751-6.
2007: Rioux-Leclercq Nathalie; Fergelot Patricia; Zerrouki Salim; Leray Emmanuelle; Jouan Florence; Bellaud Pascale; Epstein Jonathan I; Patard Jean-Jacques
Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases.
Human pathology 2007;38(10):1489-95.
2007: Lucia M Scott; Epstein Jonathan I; Goodman Phyllis J; Darke Amy K; Reuter Victor E; Civantos Francisco; Tangen Catherine M; Parnes Howard L; Lippman Scott M; La Rosa Francisco G; Kattan Michael W; Crawford E David; Ford Leslie G; Coltman Charles A; Thompson Ian M
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2007;99(18):1375-83.
2007: Sheridan Todd; Herawi Mehsati; Epstein Jonathan I; Illei Peter B
The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
The American journal of surgical pathology 2007;31(9):1351-5.
2007: Osunkoya Adeboye O; Epstein Jonathan I
Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
The American journal of surgical pathology 2007;31(9):1323-9.
2007: Epstein Jonathan I; Srigley John; Grignon David; Humphrey Peter;
Recommendations for the reporting of prostate carcinoma.
Human pathology 2007;38(9):1305-9.
2007: Kawachi Mark H; Bahnson Robert R; Barry Michael; Carroll Peter R; Carter H Ballentine; Catalona William J; Epstein Jonathan I; Etzioni Ruth B; Hemstreet George P; Howe Richard J; Kopin Jeff D; Lange Paul H; Lilja Hans; Mohler James; Moul Judd; Nadler Robert B; Patterson Stephan; Pollack Alan; Presti Joseph C; Stroup Antoinette M; Urban Donald A; Wake Robert; Wei John T;
Prostate cancer early detection. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):714-36.
2007: Chuang Ai-Ying; DeMarzo Angelo M; Veltri Robert W; Sharma Rajni B; Bieberich Charles J; Epstein Jonathan I
Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
The American journal of surgical pathology 2007;31(8):1246-55.
2007: Hansel Donna Elizabeth; Nadasdy Tibor; Epstein Jonathan I
Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
The American journal of surgical pathology 2007;31(8):1231-7.
2007: Chuang Ai-Ying; Epstein Jonathan I
Xanthoma of the prostate: a mimicker of high-grade prostate adenocarcinoma.
The American journal of surgical pathology 2007;31(8):1225-30.
2007: Tamas Ecaterina F; Nielsen Matthew E; Schoenberg Mark P; Epstein Jonathan I
Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(8):828-34.
2007: Veltri Robert W; Marlow Cameron; Khan Masood A; Miller Michael C; Epstein Jonathan I; Partin Alan W
Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis.
The Prostate 2007;67(11):1202-10.
2007: Makarov Danil V; Trock Bruce J; Humphreys Elizabeth B; Mangold Leslie A; Walsh Patrick C; Epstein Jonathan I; Partin Alan W
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
Urology 2007;69(6):1095-101.
2007: Herawi Mehsati; Epstein Jonathan I
Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
The American journal of surgical pathology 2007;31(6):889-94.
2007: Herawi Mehsati; Epstein Jonathan I
Solitary fibrous tumor on needle biopsy and transurethral resection of the prostate: a clinicopathologic study of 13 cases.
The American journal of surgical pathology 2007;31(6):870-6.
2007: Ali Tehmina Z; Epstein Jonathan I
Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases.
The American journal of surgical pathology 2007;31(5):697-705.
2007: Hansel D E; DeMarzo A M; Platz E A; Jadallah S; Hicks J; Epstein J I; Partin A W; Netto G J
Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
The Journal of urology 2007;177(5):1736-40.
2007: Owens Christopher L; Epstein Jonathan I; Netto George J
Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry.
Archives of pathology & laboratory medicine 2007;131(4):599-603.
2007: Makary Martin A; Epstein Jonathan; Pronovost Peter J; Millman E Anne; Hartmann Emily C; Freischlag Julie A
Surgical specimen identification errors: a new measure of quality in surgical care.
Surgery 2007;141(4):450-5.
2007: Tamas Ecaterina F; Epstein Jonathan I
Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
The American journal of surgical pathology 2007;31(3):390-7.
2007: Owens Christopher L; Epstein Jonathan I
Significance of denuded urothelium in papillary urothelial lesions.
The American journal of surgical pathology 2007;31(2):298-303.
2007: Hansel Donna E; Herawi Mehsati; Montgomery Elizabeth; Epstein Jonathan I
Spindle cell lesions of the adult prostate.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(1):148-58.
2007: Wild P J; Giedl J; Stoehr R; Junker K; Boehm S; van Oers J M M; Zwarthoff E C; Blaszyk H; Fine S W; Humphrey P A; Dehner L P; Amin M B; Epstein J I; Hartmann A
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.
The Journal of pathology 2007;211(1):18-25.
2007: Herawi Mehsati; De Marzo Angelo M; Kristiansen Glen; Epstein Jonathan I
Expression of CDX2 in benign tissue and adenocarcinoma of the prostate.
Human pathology 2007;38(1):72-8.
2006: Fine Samson W; Argani Pedram; DeMarzo Angelo M; Delahunt Brett; Sebo Thomas J; Reuter Victor E; Epstein Jonathan I
Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney.
The American journal of surgical pathology 2006;30(12):1554-60.
2006: Montgomery Elizabeth A; Shuster Dawn D; Burkart Ashlie L; Esteban Jose M; Sgrignoli Anita; Elwood Lori; Vaughn David J; Griffin Constance A; Epstein Jonathan I
Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
The American journal of surgical pathology 2006;30(12):1502-12.
2006: Guo Charles C; Epstein Jonathan I
Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(12):1528-35.
2006: Fine Samson W; Epstein Jonathan I
Inverted urothelial papillomas with foamy or vacuolated cytoplasm.
Human pathology 2006;37(12):1577-82.
2006: Marks Leonard S; Mazer Norman A; Mostaghel Elahe; Hess David L; Dorey Frederick J; Epstein Jonathan I; Veltri Robert W; Makarov Danil V; Partin Alan W; Bostwick David G; Macairan Maria Luz; Nelson Peter S
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2006;296(19):2351-61.
2006: Carter H Ballentine; Ferrucci Luigi; Kettermann Anna; Landis Patricia; Wright E James; Epstein Jonathan I; Trock Bruce J; Metter E Jeffrey
Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
Journal of the National Cancer Institute 2006;98(21):1521-7.
2006: Herawi Mehsati; Montgomery Elizabeth A; Epstein Jonathan I
Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
The American journal of surgical pathology 2006;30(11):1389-95.
2006: Tan Puay Hoon; Tan Hong Wui; Tan Yen; Lim Chay Ngee; Cheng Christopher; Epstein Jonathan I
Is high-grade prostatic intraepithelial neoplasia on needle biopsy different in an Asian population: a clinicopathologic study performed in Singapore.
Urology 2006;68(4):800-3.
2006: Hansel Donna E; Epstein Jonathan I
Sarcomatoid carcinoma of the prostate: a study of 42 cases.
The American journal of surgical pathology 2006;30(10):1316-21.
2006: De Marzo Angelo M; Platz Elizabeth A; Epstein Jonathan I; Ali Tehmina; Billis Anthanase; Chan Teresa Y; Cheng Liang; Datta Milton; Egevad Lars; Ertoy-Baydar Dilek; Farre Xavier; Fine Samson W; Iczkowski Kenneth A; Ittmann Michael; Knudsen Beatrice S; Loda Massimo; Lopez-Beltran Antonio; Magi-Galluzzi Cristina; Mikuz Gregor; Montironi Roldolfo; Pikarsky Eli; Pizov Galina; Rubin Mark A; Samaratunga Hema; Sebo Thomas; Sesterhenn Isabel A; Shah Rajal B; Signoretti Sabina; Simko Jeffery; Thomas George; Troncoso Patricia; Tsuzuki Toyonori T; van Leenders Geert J; Yang Ximing J; Zhou Ming; Figg William D; Hoque Ashraful; Lucia M S
A working group classification of focal prostate atrophy lesions.
The American journal of surgical pathology 2006;30(10):1281-91.
2006: Parwani Anil V; Herawi Mehsati; Epstein Jonathan I
Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases.
The American journal of surgical pathology 2006;30(10):1254-9.
2006: Netto George J; Epstein Jonathan I
Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma.
The American journal of surgical pathology 2006;30(9):1184-8.
2006: Bastian Patrick J; Gonzalgo Mark L; Aronson William J; Terris Martha K; Kane Christopher J; Amling Christopher L; Presti Joseph C; Mangold Leslie A; Humphreys Elizabeth; Epstein Jonathan I; Partin Alan W; Freedland Stephen J
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Cancer 2006;107(6):1265-72.
2006: Tamas Ecaterina F; Epstein Jonathan I
Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate.
The American journal of surgical pathology 2006;30(8):980-5.
2006: Fine Samson W; Chan Theresa Y; Epstein Jonathan I
Inverted papillomas of the prostatic urethra.
The American journal of surgical pathology 2006;30(8):975-9.
2006: Makarov Danil V; Humphreys Elizabeth B; Mangold Leslie A; Walsh Patrick C; Partin Alan W; Epstein Jonathan I; Freedland Stephen J
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
The Journal of urology 2006;176(2):554-8.
2006: Srigley John R; Amin Mahul B; Epstein Jonathan I; Grignon David J; Humphrey Peter A; Renshaw Andrew A; Wheeler Thomas M;
Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland.
Archives of pathology & laboratory medicine 2006;130(7):936-46.
2006: Guo Charles C; Fine Samson W; Epstein Jonathan I
Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
The American journal of surgical pathology 2006;30(7):883-91.
2006: Schowinsky Jeffrey T; Epstein Jonathan I
Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer.
The American journal of surgical pathology 2006;30(7):866-70.
2006: Zhou Ming; Magi-Galluzzi Cristina; Epstein Jonathan I
Prostate basal cell lesions can be negative for basal cell keratins: a diagnostic pitfall.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2006;28(3):125-9.
2006: Fine Samson W; McCarthy Denis M; Chan Theresa Y; Epstein Jonathan I; Argani Pedram
Malignant solitary fibrous tumor of the kidney: report of a case and comprehensive review of the literature.
Archives of pathology & laboratory medicine 2006;130(6):857-61.
2006: Herawi Mehsati; Epstein Jonathan I
Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases.
The American journal of surgical pathology 2006;30(6):694-704.
2006: Fine Samson W; Reuter Victor E; Epstein Jonathan I; Argani Pedram
Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma.
The American journal of surgical pathology 2006;30(5):593-9.
2006: Epstein Jonathan I
What's new in prostate cancer disease assessment in 2006?
Current opinion in urology 2006;16(3):146-51.
2006: Herawi Mehsati; Leppert John T; Thomas George V; De Kernion Jean B; Epstein Jonathan I
Implants of noninvasive papillary urothelial carcinoma in peritoneum and ileocolonic neobladder: support for "seed and soil" hypothesis of bladder recurrence.
Urology 2006;67(4):746-50.
2006: Egevad Lars; Allsbrook William C; Epstein Jonathan I
Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists.
Human pathology 2006;37(3):292-7.
2006: Herawi Mehsati; Parwani Anil V; Chan Theresa; Ali Syed Z; Epstein Jonathan I
Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation.
The American journal of surgical pathology 2006;30(3):345-50.
2006: Warlick Christopher; Trock Bruce J; Landis Patricia; Epstein Jonathan I; Carter H Ballentine
Delayed versus immediate surgical intervention and prostate cancer outcome.
Journal of the National Cancer Institute 2006;98(5):355-7.
2006: Epstein Jonathan I; Herawi Mehsati
Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
The Journal of urology 2006;175(3 Pt 1):820-34.
2006: Parwani Anil V; Herawi Mehsati; Volmar Keith; Tsay Shyh-Haw; Epstein Jonathan I
Urothelial carcinoma with rhabdoid features: report of 6 cases.
Human pathology 2006;37(2):168-72.
2006: Egevad Lars; Allsbrook William C; Epstein Jonathan I
Current practice of diagnosis and reporting of prostatic intraepithelial neoplasia and glandular atypia among genitourinary pathologists.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(2):180-5.
2006: Baydar Dilek; Amin Mahul B; Epstein Jonathan I
Osteoclast-rich undifferentiated carcinomas of the urinary tract.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(2):161-71.
2006: Epstein Jonathan I; Allsbrook William C; Amin Mahul B; Egevad Lars L
Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
Advances in anatomic pathology 2006;13(1):57-9.
2006: Gonzalgo Mark L; Bastian Patrick J; Mangold Leslie A; Trock Bruce J; Epstein Jonathan I; Walsh Patrick C; Partin Alan W
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.
Urology 2006;67(1):115-9.
2006: Herawi Mehsati; Kahane Hillel; Cavallo Christina; Epstein Jonathan I
Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled.
The Journal of urology 2006;175(1):121-4.
2006: Giedl Johannes; Wild Peter J; Stoehr Robert; Junker Kerstin; Boehm Stefan; van Oers Johanna M M; Zwarthoff Ellen C; Blaszyk Hagen; Fine Samson W; Humphrey Peter A; Dehner Louis P; Amin Mahul B; Epstein Jonathan I; Hartmann Arndt
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]
Verhandlungen der Deutschen Gesellschaft für Pathologie 2006;90():253-63.
2005: Rosenbaum Eli; Hoque Mohammad Obaidul; Cohen Yoram; Zahurak Marianna; Eisenberger Mario A; Epstein Jonathan I; Partin Alan W; Sidransky David
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8321-5.
2005: Andriole Gerald; Bostwick David; Civantos Francisco; Epstein Jonathan; Lucia M Scott; McConnell John; Roehrborn Claus G
The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.
The Journal of urology 2005;174(6):2098-104.
2005: Aydin Hakan; Zhou Ming; Herawi Mehsati; Epstein Jonathan I
Number and location of nucleoli and presence of apoptotic bodies in diagnostically challenging cases of prostate adenocarcinoma on needle biopsy.
Human pathology 2005;36(11):1172-7.
2005: Fine Samson W; Humphrey Peter A; Dehner Louis P; Amin Mahul B; Epstein Jonathan I
Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
The Journal of urology 2005;174(5):1976-80.
2005: Freedland Stephen J; Grubb Kelly A; Yiu Sindy K; Nielsen Matthew E; Mangold Leslie A; Isaacs William B; Epstein Jonathan I; Partin Alan W
Obesity and capsular incision at the time of open retropubic radical prostatectomy.
The Journal of urology 2005;174(5):1798-801; discussion 1801.
2005: Lewin Marc R; Dilworth H Parry; Abu Alfa Amer K; Epstein Jonathan I; Montgomery Elizabeth
Mucosal benign epithelioid nerve sheath tumors.
The American journal of surgical pathology 2005;29(10):1310-5.
2005: Novak T E; Lakshmanan Y; Frimberger D; Epstein J I; Gearhart J P
Polyps in the exstrophic bladder. A cause for concern?
The Journal of urology 2005;174(4 Pt 2):1522-6; discussion 1526.
2005: Chan Theresa Y; Epstein Jonathan I
Patient and urologist driven second opinion of prostate needle biopsies.
The Journal of urology 2005;174(4 Pt 1):1390-4; discussion 1394; author reply 1394.
2005: Epstein Jonathan I; Allsbrook William C; Amin Mahul B; Egevad Lars L;
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
The American journal of surgical pathology 2005;29(9):1228-42.
2005: Ali Tehmina Z; Epstein Jonathan I
Perineural involvement by benign prostatic glands on needle biopsy.
The American journal of surgical pathology 2005;29(9):1159-63.
2005: Oyama Tetsunari; Allsbrook William C; Kurokawa Kohei; Matsuda Hadzki; Segawa Atsuki; Sano Takaaki; Suzuki Keiji; Epstein Jonathan I
A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States.
Archives of pathology & laboratory medicine 2005;129(8):1004-10.
2005: Epstein Jonathan I; Sanderson Harriete; Carter H Ballentine; Scharfstein Daniel O
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
Urology 2005;66(2):356-60.
2005: Parikh Parin; Chan Theresa Y; Epstein Jonathan I; Argani Pedram
Incidental stromal-predominant mixed epithelial-stromal tumors of the kidney: a mimic of intraparenchymal renal leiomyoma.
Archives of pathology & laboratory medicine 2005;129(7):910-4.
2005: Fine Samson W; Epstein Jonathan I
Minute foci of Gleason score 8-10 on prostatic needle biopsy: a morphologic analysis.
The American journal of surgical pathology 2005;29(7):962-8.
2005: Herawi Mehsati; Parwani Anil V; Irie Junji; Epstein Jonathan I
Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion.
The American journal of surgical pathology 2005;29(7):874-80.
2005: Baydar Dilek Ertoy; Allan Robert W; Castellan Miguel; Labbie Andrew; Epstein Jonathan I
Anaplastic signet ring cell carcinoma arising in gastrocystoplasty.
Urology 2005;65(6):1226.
2005: Epstein Jonathan I; Amin Mahul; Boccon-Gibod Liliane; Egevad Lars; Humphrey Peter A; Mikuz Gregor; Newling Don; Nilsson Sten; Sakr Wael; Srigley John R; Wheeler Thomas M; Montironi Rodolfo
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.
Scandinavian journal of urology and nephrology. Supplementum 2005;(216):34-63.
2005: Amin Mahul; Boccon-Gibod Liliane; Egevad Lars; Epstein Jonathan I; Humphrey Peter A; Mikuz Gregor; Newling Don; Nilsson Sten; Sakr Wael; Srigley John R; Wheeler Thomas M; Montironi Rodolfo
Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens.
Scandinavian journal of urology and nephrology. Supplementum 2005;(216):20-33.
2005: Srigley John R; Amin Mahul; Boccon-Gibod Liliane; Egevad Lars; Epstein Jonathan I; Humphrey Peter A; Mikuz Gregor; Newling Don; Nilsson Sten; Sakr Wael; Wheeler Thomas M; Montironi Rodolfo
Prognostic and predictive factors in prostate cancer: historical perspectives and recent international consensus initiatives.
Scandinavian journal of urology and nephrology. Supplementum 2005;(216):8-19.
2005: Rioux-Leclercq Nathalie; Leray Emmanuelle; Patard Jean-Jacques; Lobel Bernard; Guillé François; Jouan Florence; Bellaud Pascale; Epstein Jonathan I
The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
Human pathology 2005;36(5):531-5.
2005: Hosler Gregory A; Epstein Jonathan I
Basal cell hyperplasia: an unusual diagnostic dilemma on prostate needle biopsies.
Human pathology 2005;36(5):480-5.
2005: Freedland Stephen J; Isaacs William B; Mangold Leslie A; Yiu Sindy K; Grubb Kelly A; Partin Alan W; Epstein Jonathan I; Walsh Patrick C; Platz Elizabeth A
Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2883-8.
2005: Fine Samson W; Pindzola J Ander; Uhlman Eric J; Epstein Jonathan I
Pathologic quiz case: a 64-year-old man with an adrenal mass. Myxoid adrenal cortical neoplasm.
Archives of pathology & laboratory medicine 2005;129(4):541-2.
2005: Aydin Hakan; Young Robert H; Ronnett Brigitte M; Epstein Jonathan I
Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma.
The American journal of surgical pathology 2005;29(4):520-3.
2005: Cao Dengfeng; Hafez Mike; Berg Karin; Murphy Kathleen; Epstein Jonathan I
Little or no residual prostate cancer at radical prostatectomy: vanishing cancer or switched specimen?: a microsatellite analysis of specimen identity.
The American journal of surgical pathology 2005;29(4):467-73.
2005: Tsuzuki Toyonori; Epstein Jonathan I
Fibroepithelial polyp of the lower urinary tract in adults.
The American journal of surgical pathology 2005;29(4):460-6.
2005: Herawi Mehsati; Parwani Anil V; Edlow Donald; Smolev James K; Epstein Jonathan I
Glomus tumor of renal pelvis: a case report and review of the literature.
Human pathology 2005;36(3):299-302.
2005: Freedland Stephen J; Sokoll Lori J; Mangold Leslie A; Bruzek Debra J; Mohr Phaedre; Yiu Sindy K; Epstein Jonathan I; Partin Alan W
Serum leptin and pathological findings at the time of radical prostatectomy.
The Journal of urology 2005;173(3):773-6.
2005: Tsuzuki Toyonori; Hernandez David J; Aydin Hakan; Trock Bruce; Walsh Patrick C; Epstein Jonathan I
Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.
The Journal of urology 2005;173(2):450-3.
2005: Hernandez David J; Epstein Jonathan I; Trock Bruce J; Tsuzuki Toyonori; Carter H Ballentine; Walsh Patrick C
Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle?
The Journal of urology 2005;173(2):446-9.
2005: Rogers Craig G; Parwani Anil; Tekes Aylin; Schoenberg Mark P; Epstein Jonathan I
Carcinosarcoma of the prostate with urothelial and squamous components.
The Journal of urology 2005;173(2):439-40.
2005: Egevad Lars; Allsbrook William C; Epstein Jonathan I
Current practice of Gleason grading among genitourinary pathologists.
Human pathology 2005;36(1):5-9.
2004: Broussard Jennifer N; Tan Puay Hoon; Epstein Jonathan I
Atypia in inverted urothelial papillomas: pathology and prognostic significance.
Human pathology 2004;35(12):1499-504.
2004: Magi-Galluzzi Cristina; Epstein Jonathan I
Urothelial papilloma of the bladder: a review of 34 de novo cases.
The American journal of surgical pathology 2004;28(12):1615-20.
2004: Tsuzuki Toyonori; Magi-Galluzzi Cristina; Epstein Jonathan I
ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.
The American journal of surgical pathology 2004;28(12):1609-14.
2004: Palapattu Ganesh S; Allaf Mohamad E; Trock Bruce J; Epstein Jonathan I; Walsh Patrick C
Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.
The Journal of urology 2004;172(5 Pt 1):1860-4.
2004: Khan Masood A; Mangold Leslie A; Epstein Jonathan I; Boitnott John K; Walsh Patrick C; Partin Alan W
Impact of surgical delay on long-term cancer control for clinically localized prostate cancer.
The Journal of urology 2004;172(5 Pt 1):1835-9.
2004: Bastian Patrick J; Mangold Leslie A; Epstein Jonathan I; Partin Alan W
Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis.
Cancer 2004;101(9):2001-5.
2004: Rioux-Leclercq Nathalie; Delcros Jean-Guy; Bansard Jean-Yves; Epstein Jonathan I; Patard Jean-Jacques; Lobel Bernard; Guillé François; Jouan Florence; Bellaud Pascale; Moulinoux Jacques-Philippe
Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma.
Human pathology 2004;35(10):1279-84.
2004: Farinola Maryam A; Epstein Jonathan I
Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
Human pathology 2004;35(10):1272-8.
2004: Truskinovsky Alexander M; Sanderson Harriete; Epstein Jonathan I
Characterization of minute adenocarcinomas of prostate at radical prostatectomy.
Urology 2004;64(4):733-7.
2004: Parwani Anil V; Epstein Jonathan I; Ali Syed Z
Pathologic quiz case: a 2-month-old male infant with a large hydrocele. Epidermoid cyst of the scrotum.
Archives of pathology & laboratory medicine 2004;128(10):e135-6.
2004: Aydin Hakan; Tsuzuki Toyonori; Hernandez David; Walsh Patrick C; Partin Alan W; Epstein Jonathan I
Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression.
Urology 2004;64(3):551-5.
2004: Tokumaru Yutaka; Harden Susan V; Sun Dong-Il; Yamashita Keishi; Epstein Jonathan I; Sidransky David
Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5518-22.
2004: Parwani Anil V; Cao Dengfeng; Epstein Jonathan I
Pathologic quiz case: a 35-year-old man with hematuria. Paraganglioma involving the prostate.
Archives of pathology & laboratory medicine 2004;128(8):e104-6.
2004: Chan Theresa Y; Epstein Jonathan I
Radiation or chemotherapy cystitis with "pseudocarcinomatous" features.
The American journal of surgical pathology 2004;28(7):909-13.
2004: Schaeffer Edward M; Epstein Jonathan I; Walsh Patrick C
Amyloidosis of the seminal vesicle and hematospermia.
The Journal of urology 2004;171(6 Pt 1):2382.
2004: Zhou Ming; Tokumaru Yutaka; Sidransky David; Epstein Jonathan I
Quantitative GSTP1 methylation levels correlate with Gleason grade and tumor volume in prostate needle biopsies.
The Journal of urology 2004;171(6 Pt 1):2195-8.
2004: Veltri Robert W; Khan Masood A; Miller M Craig; Epstein Jonathan I; Mangold Leslie A; Walsh Patrick C; Partin Alan W
Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3465-73.
2004: Freedland Stephen J; Mangold Leslie A; Epstein Jonathan I; Partin Alan W
Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
Urology 2004;63(5):887-91.
2004: Parwani Anil V; Levi Angelique W; Epstein Jonathan I; Ali Syed Z
Urinary bladder biopsy with denuded mucosa: denuding cystitis-cytopathologic correlates.
Diagnostic cytopathology 2004;30(5):297-300.
2004: Parwani Anil V; Kronz J D; Genega E M; Gaudin P; Chang S; Epstein J I
Prostate carcinoma with squamous differentiation: an analysis of 33 cases.
The American journal of surgical pathology 2004;28(5):651-7.
2004: Bishara Tarek; Ramnani Dharam M; Epstein Jonathan I
High-grade prostatic intraepithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern.
The American journal of surgical pathology 2004;28(5):629-33.
2004: Freedland Stephen J; Partin Alan W; Epstein Jonathan I; Walsh Patrick C
Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.
Cancer 2004;100(8):1646-9.
2004: Mosse Claudio A; Magi-Galluzzi Cristina; Tsuzuki Toyonori; Epstein Jonathan I
The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens.
The American journal of surgical pathology 2004;28(3):394-8.
2004: Bastacky Sheldon; Cieply Kathleen; Sherer Carol; Dhir Rajiv; Epstein Jonathan I
Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy.
Human pathology 2004;35(3):281-9.
2004: Parwani Anil V; Rosenthal Dorothy L; Epstein Jonathan I; Ali Syed Z
Pathologic quiz case: a 3-year-old girl with dysuria and urinary incontinence. Primary embryonal rhabdomyosarcoma of the urinary bladder.
Archives of pathology & laboratory medicine 2004;128(3):357-8.
2004: Epstein Jonathan I
Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(3):307-15.
2004: Zhou Ming; Aydin Hakan; Kanane Hillel; Epstein Jonathan I
How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
The American journal of surgical pathology 2004;28(2):239-43.
2004: De Marzo Angelo M; DeWeese Theodore L; Platz Elizabeth A; Meeker Alan K; Nakayama Masashi; Epstein Jonathan I; Isaacs William B; Nelson William G
Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment.
Journal of cellular biochemistry 2004;91(3):459-77.
2004: Halushka Marc K; Kahane Hillel; Epstein Jonathan I
Negative 34betaE12 staining in a small focus of atypical glands on prostate needle biopsy: a follow-up study of 332 cases.
Human pathology 2004;35(1):43-6.
2004: Zhou Ming; Epstein Jonathan I; Young Robert H
Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens.
The American journal of surgical pathology 2004;28(1):94-100.
2003: Khan Masood A; Walsh Patrick C; Miller M Craig; Bales Wesley D; Epstein Jonathan I; Mangold Leslie A; Partin Alan W; Veltri Robert W
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.
Cancer 2003;98(12):2583-91.
2003: Zhou Ming; Epstein Jonathan I
The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers.
Pathology 2003;35(6):472-9.
2003: Khan Masood A; Carter H Ballentine; Epstein Jonathan I; Miller Michael C; Landis Patricia; Walsh Patrick W; Partin Alan W; Veltri Robert W
Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?
The Journal of urology 2003;170(6 Pt 1):2274-8.
2003: Magi-Galluzzi Cristina; Epstein Jonathan I
Threshold for diagnosing prostate cancer over time.
Human pathology 2003;34(11):1116-8.
2003: Khan Masood A; Partin Alan W; Mangold Leslie A; Epstein Jonathan I; Walsh Patrick C
Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer.
Urology 2003;62(5):866-71.
2003: Harden Susan V; Sanderson Harriette; Goodman Steven N; Partin Alan A W; Walsh Patrick C; Epstein Jonathan I; Sidransky David
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies.
Journal of the National Cancer Institute 2003;95(21):1634-7.
2003: Rogers Craig G; Epstein Jonathan I; Pavlovich Christian P
Adenofibroma of the testis discovered at exploration for torsion after trauma.
The Journal of urology 2003;170(5):1943.
2003: Kunz George M; Epstein Jonathan I
Should each core with prostate cancer be assigned a separate gleason score?
Human pathology 2003;34(9):911-4.
2003: Volmar Keith E; Chan Theresa Y; De Marzo Angelo M; Epstein Jonathan I
Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.
The American journal of surgical pathology 2003;27(9):1243-52.
2003: Nakayama Masashi; Bennett Christina J; Hicks Jessica L; Epstein Jonathan I; Platz Elizabeth A; Nelson William G; De Marzo Angelo M
Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.
The American journal of pathology 2003;163(3):923-33.
2003: Epstein Jonathan I
The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?
Critical reviews in oncology/hematology 2003;47(2):83-9.
2003: Magi-Galluzzi Cristina; Luo Jun; Isaacs William B; Hicks Jessica L; de Marzo Angelo M; Epstein Jonathan I
Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
The American journal of surgical pathology 2003;27(8):1128-33.
2003: Allan Robert W; Sanderson Harriete; Epstein Jonathan I
Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density.
The Journal of urology 2003;170(2 Pt 1):370-2.
2003: Mikami Yoshiki; Manabe Toshiaki; Epstein Jonathan I; Shiraishi Taizo; Furusato Masakuni; Tsuzuki Toyonori; Matsuno Yoshihiro; Sasano Hironobu
Accuracy of gleason grading by practicing pathologists and the impact of education on improving agreement.
Human pathology 2003;34(7):658-65.
2003: Haddadin Mary H; Hawkins Anita L; Long Patricia; Morsberger Laura A; Depew Dawn; Epstein Jonathan I; Griffin Constance A
Cytogenetic study of malignant triton tumor: a case report.
Cancer genetics and cytogenetics 2003;144(2):100-5.
2003: Chan Theresa Y; Mikolajczyk Stephen D; Lecksell Kristin; Shue Matthew J; Rittenhouse Harry G; Partin Alan W; Epstein Jonathan I
Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen.
Urology 2003;62(1):177-81.
2003: Khan Masood A; Han Misop; Partin Alan W; Epstein Jonathan I; Walsh Patrick C
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
Urology 2003;62(1):86-91; discussion 91-2.
2003: Zhou Ming; Jiang Zhong; Epstein Jonathan I
Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
The American journal of surgical pathology 2003;27(6):772-8.
2003: Weir Edward G; Epstein Jonathan I
Incidental small lymphocytic lymphoma/chronic lymphocytic leukemia in pelvic lymph nodes excised at radical prostatectomy.
Archives of pathology & laboratory medicine 2003;127(5):567-72.
2003: DeMarzo Angelo M; Nelson William G; Isaacs William B; Epstein Jonathan I
Pathological and molecular aspects of prostate cancer.
Lancet 2003;361(9361):955-64.
2003: Allen Elizabeth A; Brinker David A; Coppola Domenico; Diaz Jose I; Epstein Jonathan I
Multilocular prostatic cystadenoma with high-grade prostatic intraepithelial neoplasia.
Urology 2003;61(3):644.
2003: Harden Susan V; Guo Zhongmin; Epstein Jonathan I; Sidransky David
Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
The Journal of urology 2003;169(3):1138-42.
2003: Kronz Joseph D; Milord Rolando; Wilentz Robb; Weir Edward G; Schreiner Stephanie R; Epstein Jonathan I
Lesions missed on prostate biopsies in cases sent in for consultation.
The Prostate 2003;54(4):310-4.
2003: Haese Alexander; Chaudhari Manisha; Miller M Craig; Epstein Jonathan I; Huland Hartwig; Palisaar Juri; Graefen Markus; Hammerer Peter; Poole Edward C; O'Dowd Gerard J; Partin Alan W; Veltri Robert W
Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.
Cancer 2003;97(4):969-78.
2003: Rioux-Leclercq Nathalie C; Epstein Jonathan I
Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney.
Archives of pathology & laboratory medicine 2003;127(2):E89-92.
2003: Magi-Galluzzi Cristina; Sanderson Harriete; Epstein Jonathan I
Atypia in nonneoplastic prostate glands after radiotherapy for prostate cancer: duration of atypia and relation to type of radiotherapy.
The American journal of surgical pathology 2003;27(2):206-12.
2003: Han Misop; Partin Alan W; Zahurak Marianna; Piantadosi Steven; Epstein Johnathan I; Walsh Patrick C
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
The Journal of urology 2003;169(2):517-23.
2002: Gretzer Matthew B; Epstein Jonathan I; Pound Charles R; Walsh Patrick C; Partin Alan W
Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence.
Urology 2002;60(6):1034-9.
2002: Rioux-Leclercq Nathalie C; Chan David Y; Epstein Jonathan I
Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma.
Urology 2002;60(4):666-9.
2002: Veltri Robert W; Marks Leonard S; Miller M Craig; Bales Wes D; Fan John; Macairan Maria Luz; Epstein Jonathan I; Partin Alan W
Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism.
Urology 2002;60(4):617-22.
2002: Sokoll Lori J; Mangold Leslie A; Partin Alan W; Epstein Jonathan I; Bruzek Debra J; Dunn Willard; Mohr Phaedre; Wallerson Gail; Chan Daniel W
Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men.
Urology 2002;60(4 Suppl 1):18-23.
2002: Oliai Bahram R; Kahane Hillel; Epstein Jonathan I
Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody.
The American journal of surgical pathology 2002;26(9):1151-60.
2002: Haese Alexander; Epstein Jonathan I; Huland Hartwig; Partin Alan W
Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma.
Cancer 2002;95(5):1016-21.
2002: Viglione Michael P; Potter Stephen; Partin Alan W; Lesniak Maciej S; Epstein Jonathan I
Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?
Human pathology 2002;33(8):796-800.
2002: Samaratunga Hemamali; Makarov Danil V; Epstein Jonathan I
Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.
Urology 2002;60(2):315-9.
2002: Veltri Robert W; Miller M Craig; Mangold Leslie A; O'Dowd Gerard J; Epstein Jonathan I; Partin Alan W
Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
The Journal of urology 2002;168(1):100-4.
2002: Makarov Danil V; Sanderson Harriete; Partin Alan W; Epstein Jonathan I
Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
The Journal of urology 2002;167(6):2440-2.
2002: Srodon Monica; Epstein Jonathan I
Central zone histology of the prostate: a mimicker of high-grade prostatic intraepithelial neoplasia.
Human pathology 2002;33(5):518-23.
2002: Swierczynski Sharon L; Epstein Jonathan I
Prognostic significance of atypical papillary urothelial hyperplasia.
Human pathology 2002;33(5):512-7.
2002: Carter H Ballentine; Walsh Patrick C; Landis Patricia; Epstein Jonathan I
Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.
The Journal of urology 2002;167(3):1231-4.
2002: Seibel Jeffrey L; Prasad Saket; Weiss Robert E; Bancila Edita; Epstein Jonathan I
Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.
Human pathology 2002;33(2):236-41.
2002: Gillespie John W; Best Carolyn J M; Bichsel Verena E; Cole Kristina A; Greenhut Susan F; Hewitt Stephen M; Ahram Mamoun; Gathright Yvonne B; Merino Maria J; Strausberg Robert L; Epstein Jonathan I; Hamilton Stanley R; Gannot Gallya; Baibakova Galina V; Calvert Valerie S; Flaig Michael J; Chuaqui Rodrigo F; Herring Judi C; Pfeifer John; Petricoin Emmanuel F; Linehan W Marston; Duray Paul H; Bova G Steven; Emmert-Buck Michael R
Evaluation of non-formalin tissue fixation for molecular profiling studies.
The American journal of pathology 2002;160(2):449-57.
2002: Rioux-Leclercq Nathalie C; Epstein Jonathan I
Unusual morphologic patterns of basal cell hyperplasia of the prostate.
The American journal of surgical pathology 2002;26(2):237-43.
2002: O'Malley Kiaran J; Pound Charles R; Walsh Patrick C; Epstein Jonathan I; Partin Alan W
Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy.
Urology 2002;59(1):85-90.
2001: Partin A W; Mangold L A; Lamm D M; Walsh P C; Epstein J I; Pearson J D
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.
Urology 2001;58(6):843-8.
2001: Argani P; Epstein J I
Inverted (Hobnail) high-grade prostatic intraepithelial neoplasia (PIN): report of 15 cases of a previously undescribed pattern of high-grade PIN.
The American journal of surgical pathology 2001;25(12):1534-9.
2001: Chan T Y; Chan D Y; Stutzman K L; Epstein J I
Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?
The Journal of urology 2001;166(6):2181-4.
2001: Rioux-Leclercq N; Epstein J I; Bansard J Y; Turlin B; Patard J J; Manunta A; Chan T; Ramee M P; Lobel B; Moulinoux J P
Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
Human pathology 2001;32(11):1209-15.
2001: Barocas D A; Han M; Epstein J I; Chan D Y; Trock B J; Walsh P C; Partin A W
Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
Urology 2001;58(5):746-51.
2001: Epstein J I; Walsh P C; Carter H B
Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease.
The Journal of urology 2001;166(5):1688-91.
2001: Epstein J I
Grade I prostate cancer.
Human pathology 2001;32(10):1141-2.
2001: Fisher C; Goldblum J R; Epstein J I; Montgomery E
Leiomyosarcoma of the paratesticular region: a clinicopathologic study.
The American journal of surgical pathology 2001;25(9):1143-9.
2001: Milord R A; Lecksell K; Epstein J I
An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ.
Human pathology 2001;32(9):997-1002.
2001: Epstein J I
Pathologic assessment of the surgical specimen.
The Urologic clinics of North America 2001;28(3):567-94.
2001: Han M; Partin A W; Pound C R; Epstein J I; Walsh P C
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.
The Urologic clinics of North America 2001;28(3):555-65.
2001: Yaycioglu O; Roberts W W; Chan T; Epstein J I; Marshall F F; Kavoussi L R
Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based model.
Urology 2001;58(2):141-5.
2001: Kronz J D; Allan C H; Shaikh A A; Epstein J I
Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy.
The American journal of surgical pathology 2001;25(8):1079-85.
2001: Levi A W; Potter S R; Schoenberg M P; Epstein J I
Clinical significance of denuded urothelium in bladder biopsy.
The Journal of urology 2001;166(2):457-60.
2001: Han M; Partin A W; Piantadosi S; Epstein J I; Walsh P C
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer.
The Journal of urology 2001;166(2):416-9.
2001: Epstein J I; Potter S R
The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies.
The Journal of urology 2001;166(2):402-10.
2001: Chan T Y; Epstein J I
In situ adenocarcinoma of the bladder.
The American journal of surgical pathology 2001;25(7):892-9.
2001: Cina S J; Epstein J I; Endrizzi J M; Harmon W J; Seay T M; Schoenberg M P
Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder.
Human pathology 2001;32(6):630-7.
2001: Allan C H; Epstein J I
Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma.
The American journal of surgical pathology 2001;25(6):802-8.
2001: Oliai B R; Kahane H; Epstein J I
A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy.
The American journal of surgical pathology 2001;25(6):794-801.
2001: Epstein J I; Walsh P C; Carter H B
Importance of posterolateral needle biopsies in the detection of prostate cancer.
Urology 2001;57(6):1112-6.
2001: Roberts W W; Bergstralh E J; Blute M L; Slezak J M; Carducci M; Han M; Epstein J I; Eisenberger M A; Walsh P C; Partin A W
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy.
Urology 2001;57(6):1033-7.
2001: Parwani A V; Husain A N; Epstein J I; Beckwith J B; Argani P
Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation.
Human pathology 2001;32(5):506-12.
2001: Sehdev A E; Pan C C; Epstein J I
Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma.
Human pathology 2001;32(5):494-9.
2001: Cina S J; Lancaster-Weiss K J; Lecksell K; Epstein J I
Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
Archives of pathology & laboratory medicine 2001;125(5):646-51.
2001: Carter H B; Landis P K; Epstein J I; Walsh P C
Expectant management of prostate cancer with curative intent.
European urology 2001;39 Suppl 4():24.
2001: Bova G S; Parmigiani G; Epstein J I; Wheeler T; Mucci N R; Rubin M A
Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading.
Human pathology 2001;32(4):417-27.
2001: Kronz J D; Shaikh A A; Epstein J I
High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
Human pathology 2001;32(4):389-95.
2001: Han M; Piantadosi S; Zahurak M L; Sokoll L J; Chan D W; Epstein J I; Walsh P C; Partin A W
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.
Urology 2001;57(4):707-11.
2001: Marks L S; Epstein J I; Partin A W
The role of prostate needle biopsy in evaluation of chemopreventive agents.
Urology 2001;57(4 Suppl 1):191-3.
2001: Epstein J I
Pathologists and the judicial process: how to avoid it.
The American journal of surgical pathology 2001;25(4):527-37.
2001: Jimenez R E; Eble J N; Reuter V E; Epstein J I; Folpe A L; de Peralta-Venturina M; Tamboli P; Ansell I D; Grignon D J; Young R H; Amin M B
Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(3):157-63.
2001: Han M; Pound C R; Potter S R; Partin A W; Epstein J I; Walsh P C
Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
The Journal of urology 2001;165(3):864-6.
2001: Kronz J D; Shaikh A A; Epstein J I
Atypical cribriform lesions on prostate biopsy.
The American journal of surgical pathology 2001;25(2):147-55.
2001: Allsbrook W C; Mangold K A; Johnson M H; Lane R B; Lane C G; Epstein J I
Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.
Human pathology 2001;32(1):81-8.
2001: Allsbrook W C; Mangold K A; Johnson M H; Lane R B; Lane C G; Amin M B; Bostwick D G; Humphrey P A; Jones E C; Reuter V E; Sakr W; Sesterhenn I A; Troncoso P; Wheeler T M; Epstein J I
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.
Human pathology 2001;32(1):74-80.
2000: Simon I; Snow P B; Marks L S; Christens-Barry W A; Epstein J I; Bluemke D A; Partin A W
Neural network prediction of prostate tissue composition based on magnetic resonance imaging analysis. A pilot study.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2000;22(6):445-52.
2000: Potter S R; Mangold L A; Shue M J; Taylor D C; Lecksell K L; Epstein J I; Walsh P C; Partin A W
Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy.
Cancer 2000;89(12):2577-86.
2000: Han M; Snow P B; Epstein J I; Chan T Y; Jones K A; Walsh P C; Partin A W
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.
Urology 2000;56(6):994-9.
2000: Chow N H; Cairns P; Eisenberger C F; Schoenberg M P; Taylor D C; Epstein J I; Sidransky D
Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer.
International journal of cancer. Journal international du cancer 2000;89(6):514-8.
2000: Chan T Y; Partin A W; Walsh P C; Epstein J I
Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy.
Urology 2000;56(5):823-7.
2000: Kronz J D; Silberman M A; Allsbrook W C; Epstein J I
A web-based tutorial improves practicing pathologists' Gleason grading of images of prostate carcinoma specimens obtained by needle biopsy: validation of a new medical education paradigm.
Cancer 2000;89(8):1818-23.
2000: Epstein J I
Pathologists should retain their individuality!
The American journal of surgical pathology 2000;24(10):1443-4.
2000: Pan C C; Chiang H; Chang Y H; Epstein J I
Tubulocystic clear cell adenocarcinoma arising within the prostate.
The American journal of surgical pathology 2000;24(10):1433-6.
2000: Milord R A; Kahane H; Epstein J I
Infarct of the prostate gland: experience on needle biopsy specimens.
The American journal of surgical pathology 2000;24(10):1378-84.
2000: Dardik M; Epstein J I
Efficacy of restaining prostate needle biopsies with high-molecular weight cytokeratin.
Human pathology 2000;31(9):1155-61.
2000: Kronz J D; Silberman M A; Allsbrook W C; Bastacky S I; Burks R T; Cina S J; Mills S E; Ross J S; Sakr W A; Tomaszewski J E; True L D; Ulbright T M; Weinstein M W; Yantiss R K; Young R H; Epstein J I
Pathology residents' use of a Web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsies.
Human pathology 2000;31(9):1044-50.
2000: Tomaszewski J E; Bear H D; Connally J A; Epstein J I; Feldman M; Foucar K; Layfield L; LiVolsi V; Sirota R L; Stoler M H; Stombler R E
Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When.
American journal of clinical pathology 2000;114(3):329-35.
2000: Argani P; Faria P A; Epstein J I; Reuter V E; Perlman E J; Beckwith J B; Ladanyi M
Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney.
The American journal of surgical pathology 2000;24(8):1087-96.
2000: Levi A W; Epstein J I
Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy.
The American journal of surgical pathology 2000;24(8):1039-46.
2000: Epstein J I; Partin A W; Potter S R; Walsh P C
Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.
Urology 2000;56(2):283-8.
2000: Brinker D A; Amin M B; de Peralta-Venturina M; Reuter V; Chan D Y; Epstein J I
Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers.
The American journal of surgical pathology 2000;24(7):988-95.
2000: Oliva E; Quinn T R; Amin M B; Eble J N; Epstein J I; Srigley J R; Young R H
Primary malignant melanoma of the urethra: a clinicopathologic analysis of 15 cases.
The American journal of surgical pathology 2000;24(6):785-96.
2000: Weir E G; Partin A W; Epstein J I
Correlation of serum prostate specific antigen and quantitative immunohistochemistry.
The Journal of urology 2000;163(6):1739-42.
2000: Ripple M G; Potter S R; Partin A W; Epstein J I
Needle biopsy of recurrent adenocarcinoma of the prostate after radical prostatectomy.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(5):521-7.
2000: Marks L S; Partin A W; Epstein J I; Tyler V E; Simon I; Macairan M L; Chan T L; Dorey F J; Garris J B; Veltri R W; Santos P B; Stonebrook K A; deKernion J B
Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.
The Journal of urology 2000;163(5):1451-6.
2000: Pan C C; Potter S R; Partin A W; Epstein J I
The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system.
The American journal of surgical pathology 2000;24(4):563-9.
2000: Epstein J I
Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made.
The American journal of surgical pathology 2000;24(4):477-8.
2000: Halachmi S; DeMarzo A M; Chow N H; Halachmi N; Smith A E; Linn J F; Nativ O; Epstein J I; Schoenberg M P; Sidransky D
Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin.
European urology 2000;37(3):350-7.
2000: Fritsch M; Epstein J I; Perlman E J; Watts J C; Argani P
Molecularly confirmed primary prostatic synovial sarcoma.
Human pathology 2000;31(2):246-50.
2000: Westra W H; Grenko R T; Epstein J
Solitary fibrous tumor of the lower urogenital tract: a report of five cases involving the seminal vesicles, urinary bladder, and prostate.
Human pathology 2000;31(1):63-8.
2000: Berman D M; Yang J; Epstein J I
Foamy gland high-grade prostatic intraepithelial neoplasia.
The American journal of surgical pathology 2000;24(1):140-4.
2000: Potter S R; Epstein J I; Partin A W
Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications.
Reviews in urology 2000;2(3):190-5.
1999: Epstein J I
How should atypical prostate needle biopsies be reported? Controversies regarding the term "ASAP".
Human pathology 1999;30(12):1401-2.
1999: De Marzo A M; Marchi V L; Epstein J I; Nelson W G
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.
The American journal of pathology 1999;155(6):1985-92.
1999: Kronz J D; Westra W H; Epstein J I
Mandatory second opinion surgical pathology at a large referral hospital.
Cancer 1999;86(11):2426-35.
1999: Brinker D A; Potter S R; Epstein J I
Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression.
The American journal of surgical pathology 1999;23(12):1471-9.
1999: Brinker D A; Ross J S; Tran T A; Jones D M; Epstein J I
Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?
The Journal of urology 1999;162(6):2036-9.
1999: Hurwitz M D; DeWeese T L; Zinreich E S; Epstein J I; Partin A W
Nuclear morphometry predicts disease-free interval for clinically localized adenocarcinoma of the prostate treated with definitive radiation therapy.
International journal of cancer. Journal international du cancer 1999;84(6):594-7.
1999: Pannek J; Lakshmanan Y; Pound C R; Lemkin P F; Epstein J I; Partin A W
Nuclear shape and nuclear matrix protein composition in prostate and seminal vesicles.
Urology 1999;54(5):934-9.
1999: Potter S R; Miller M C; Mangold L A; Jones K A; Epstein J I; Veltri R W; Partin A W
Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy.
Urology 1999;54(5):791-5.
1999: Yang X J; Lecksell K; Epstein J I
Can immunohistochemistry enhance the detection of micrometastases in pelvic lymph nodes from patients with high-grade urothelial carcinoma of the bladder?
American journal of clinical pathology 1999;112(5):649-53.
1999: Epstein J I; Walsh P C; Akingba G; Carter H B
The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer.
The Journal of urology 1999;162(5):1649-52.
1999: Häussler O; Epstein J I; Amin M B; Heitz P U; Hailemariam S
Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
Human pathology 1999;30(9):1077-86.
1999: Allen E A; Burger P C; Epstein J I
Microcystic meningioma arising in a mixed germ cell tumor of the testis: a case report.
The American journal of surgical pathology 1999;23(9):1131-5.
1999: Tickoo S K; Reuter V E; Amin M B; Srigley J R; Epstein J I; Min K W; Rubin M A; Ro J Y
Renal oncocytosis: a morphologic study of fourteen cases.
The American journal of surgical pathology 1999;23(9):1094-101.
1999: Yang X J; Lecksell K; Potter S R; Epstein J I
Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy.
Urology 1999;54(3):528-32.
1999: Epstein J I; Lecksell K; Carter H B
Prostate cancer sampled on sextant needle biopsy: significance of cancer on multiple cores from different areas of the prostate.
Urology 1999;54(2):291-4.
1999: Baisden B L; Kahane H; Epstein J I
Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy.
The American journal of surgical pathology 1999;23(8):918-24.
1999: Reuter V E; Epstein J I; Amin M B; Mostofi F K
The "WHO/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms": continued discussion.
Human pathology 1999;30(7):879-80.
1999: Ruska K M; Partin A W; Epstein J I; Kahane H
Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findings.
Urology 1999;53(6):1179-83.
1999: Subong E N; Shue M J; Epstein J I; Briggman J V; Chan P K; Partin A W
Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23.
The Prostate 1999;39(4):298-304.
1999: Lee B R; Roberts W W; Smith D G; Ko H W; Epstein J I; Lecksell K; Partin A W
Bioimpedance: novel use of a minimally invasive technique for cancer localization in the intact prostate.
The Prostate 1999;39(3):213-8.
1999: Green R; Epstein J I
Use of intervening unstained slides for immunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies.
The American journal of surgical pathology 1999;23(5):567-70.
1999: Holmes G F; Walsh P C; Pound C R; Epstein J I
Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy.
Urology 1999;53(4):752-6.
1999: De Marzo A M; Knudsen B; Chan-Tack K; Epstein J I
E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
Urology 1999;53(4):707-13.
1999: Yang X J; Lecksell K; Short K; Gottesman J; Peterson L; Bannow J; Schellhammer P F; Fitch W P; Hodge G B; Parra R; Rouse S; Waldstreicher J; Epstein J I
Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study.
Urology 1999;53(4):696-700.
1999: Marks L S; Partin A W; Dorey F J; Gormley G J; Epstein J I; Garris J B; Macairan M L; Shery E D; Santos P B; Stoner E; deKernion J B
Long-term effects of finasteride on prostate tissue composition.
Urology 1999;53(3):574-80.
1999: Brat D J; Wills M L; Lecksell K L; Epstein J I
How often are diagnostic features missed with less extensive histologic sampling of prostate needle biopsy specimens?
The American journal of surgical pathology 1999;23(3):257-62.
1999: Yang X J; Lecksell K; Gaudin P; Epstein J I
Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer.
The American journal of surgical pathology 1999;23(2):147-52.
1999: Chan T Y; Epstein J I
Follow-up of atypical prostate needle biopsies suspicious for cancer.
Urology 1999;53(2):351-5.
1999: Eisenberger C F; Walsh P C; Eisenberger M A; Chow N H; Partin A W; Mostwin J L; Marshall F F; Epstein J I; Schoenberg M
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer.
Urology 1999;53(1):175-9.
1999: Carter H B; Epstein J I; Partin A W
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease.
Urology 1999;53(1):126-30.
1999: Carducci M A; Piantadosi S; Pound C R; Epstein J I; Simons J W; Marshall F F; Partin A W
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma.
Urology 1999;53(1):44-9.
1998: Yang X J; McEntee M; Epstein J I
Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67.
Human pathology 1998;29(12):1447-50.
1998: Epstein J I; Amin M B; Reuter V R; Mostofi F K
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.
The American journal of surgical pathology 1998;22(12):1435-48.
1998: Epstein J I; Chan D W; Sokoll L J; Walsh P C; Cox J L; Rittenhouse H; Wolfert R; Carter H B
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.
The Journal of urology 1998;160(6 Pt 2):2407-11.
1998: Argani P; Walsh P C; Epstein J I
Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures: further evidence of the mesodermal origin of the prostatic central zone.
The Journal of urology 1998;160(6 Pt 1):2126-9.
1998: Epstein J I
Atypical small acinar proliferation of the prostate gland.
The American journal of surgical pathology 1998;22(11):1430-1.
1998: Allen E A; Kahane H; Epstein J I
Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy.
Urology 1998;52(5):803-7.
1998: Ruska K M; Sauvageot J; Epstein J I
Histology and cellular kinetics of prostatic atrophy.
The American journal of surgical pathology 1998;22(9):1073-7.
1998: De Marzo A M; Meeker A K; Epstein J I; Coffey D S
Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
The American journal of pathology 1998;153(3):911-9.
1998: Epstein J I
The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer.
Seminars in urologic oncology 1998;16(3):124-8.
1998: Andriole G L; Guess H A; Epstein J I; Wise H; Kadmon D; Crawford E D; Hudson P; Jackson C L; Romas N A; Patterson L; Cook T J; Waldstreicher J
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.
Urology 1998;52(2):195-201; discussion 201-2.
1998: Miller L R; Partin A W; Chan D W; Bruzek D J; Dobs A S; Epstein J I; Walsh P C
Influence of radical prostatectomy on serum hormone levels.
The Journal of urology 1998;160(2):449-53.
1998: Argani P; Carter H B; Epstein J I
Isolated vasculitis of the seminal vesicle.
Urology 1998;52(1):131-3.
1998: Epstein J I; Pound C R; Partin A W; Walsh P C
Disease progression following radical prostatectomy in men with Gleason score 7 tumor.
The Journal of urology 1998;160(1):97-100; discussion 101.
1998: Brooks J D; Weinstein M; Lin X; Sun Y; Pin S S; Bova G S; Epstein J I; Isaacs W B; Nelson W G
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(6):531-6.
1998: Lee B R; Silver R I; Partin A W; Epstein J I; Gearhart J P
A quantitative histologic analysis of collagen subtypes: the primary obstructed and refluxing megaureter of childhood.
Urology 1998;51(5):820-3.
1998: Wills M L; Sauvageot J; Partin A W; Gurganus R; Epstein J I
Ability of sextant biopsies to predict radical prostatectomy stage.
Urology 1998;51(5):759-64.
1998: Carlson G D; Calvanese C B; Kahane H; Epstein J I
Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability.
Urology 1998;51(4):525-9.
1998: Weinstein M H; Greenspan D L; Epstein J I
Diagnoses rendered on prostate needle biopsy in community hospitals.
The Prostate 1998;35(1):50-5.
1998: Oppenheimer J R; Wills M L; Epstein J I
Partial atrophy in prostate needle cores: another diagnostic pitfall for the surgical pathologist.
The American journal of surgical pathology 1998;22(4):440-5.
1998: Pannek J; Rittenhouse H G; Chan D W; Epstein J I; Walsh P C; Partin A W
The use of percent free prostate specific antigen for staging clinically localized prostate cancer.
The Journal of urology 1998;159(4):1238-42.
1998: Gaudin P B; Rosai J; Epstein J I
Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases.
The American journal of surgical pathology 1998;22(2):148-62.
1998: Kadkol S S; Brody J R; Epstein J I; Kuhajda F P; Pasternack G R
Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer.
The Prostate 1998;34(3):231-7.
1998: De Marzo A M; Bradshaw C; Sauvageot J; Epstein J I; Miller G J
CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture.
The Prostate 1998;34(3):162-8.
1998: Sauvageot J; Epstein J I
Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
The Prostate 1998;34(1):29-33.
1998: Halachmi S; De Marzo A M; Linn J F; Epstein J I; Schoenberg M P
Extensive squamous cell carcinoma in situ of the bladder masking deeply invasive disease.
The Journal of urology 1998;159(1):203.
1997: Partin A W; Briggman J V; Subong E N; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey D S; Epstein J I
Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
Urology 1997;50(5):800-8.
1997: Epstein J I; Walsh P C; Sauvageot J; Carter H B
Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
The Journal of urology 1997;158(5):1886-90.
1997: Jacobs L B; Brooks J D; Epstein J I
Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder.
Human pathology 1997;28(10):1152-7.
1997: Cadeddu J A; Partin A W; Epstein J I; Walsh P C
Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
Urology 1997;50(2):251-5.
1997: Oppenheimer J R; Kahane H; Epstein J I
Granulomatous prostatitis on needle biopsy.
Archives of pathology & laboratory medicine 1997;121(7):724-9.
1997: Henneberry J M; Kahane H; Humphrey P A; Keetch D W; Epstein J I
The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy.
The American journal of surgical pathology 1997;21(6):725-8.
1997: Carter H B; Sauvageot J; Walsh P C; Epstein J I
Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.
The Journal of urology 1997;157(6):2206-9.
1997: Steinberg D M; Sauvageot J; Piantadosi S; Epstein J I
Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings.
The American journal of surgical pathology 1997;21(5):566-76.
1997: Cina S J; Silberman M A; Kahane H; Epstein J I
Diagnosis of Cowper's glands on prostate needle biopsy.
The American journal of surgical pathology 1997;21(5):550-5.
1997: Thiel R; Pearson J D; Epstein J I; Walsh P C; Carter H B
Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer.
Urology 1997;49(5):716-20.
1997: Carter H B; Epstein J I; Chan D W; Fozard J L; Pearson J D
Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.
JAMA : the journal of the American Medical Association 1997;277(18):1456-60.
1997: Pound C R; Partin A W; Epstein J I; Walsh P C
Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.
The Urologic clinics of North America 1997;24(2):395-406.
1997: Sipos E P; Tamargo R J; Epstein J I; North R B
Primary intracerebral small-cell osteosarcoma in an adolescent girl: report of a case.
Journal of neuro-oncology 1997;32(2):169-74.
1997: Gaudin P B; Sesterhenn I A; Wojno K J; Mostofi F K; Epstein J I
Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens.
Urology 1997;49(4):558-63.
1997: Wills M L; Hamper U M; Partin A W; Epstein J I
Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens.
Urology 1997;49(3):367-73.
1997: Cina S J; Epstein J I
Adenocarcinoma of the prostate with atrophic features.
The American journal of surgical pathology 1997;21(3):289-95.
1997: DiGiuseppe J A; Sauvageot J; Epstein J I
Increasing incidence of minimal residual cancer in radical prostatectomy specimens.
The American journal of surgical pathology 1997;21(2):174-8.
1997: Silver R I; Partin A W; Epstein J I; Chan D W; Carter H B; Jeffs R D; Gearhart J P
Prostate-specific antigen in men born with bladder exstrophy.
Urology 1997;49(2):253-6.
1997: Silberman M A; Partin A W; Veltri R W; Epstein J I
Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate.
Cancer 1997;79(4):772-9.
1997: Weinstein L J; Epstein J I; Edlow D; Westra W H
Static image analysis of skin specimens: the application of telepathology to frozen section evaluation.
Human pathology 1997;28(1):30-5.
1997: Weinstein M H; Epstein J I
Telepathology diagnosis of prostrate needle biopsies.
Human pathology 1997;28(1):22-9.
1997: Epstein J I; Sauvageot J
Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression?
The Journal of urology 1997;157(1):241-3.
1997: Pound C R; Walsh P C; Epstein J I; Chan D W; Partin A W
Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer.
World journal of urology 1997;15(6):373-7.
1997: Carter H B; Epstein J I
Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate.
World journal of urology 1997;15(6):359-63.
1996: Pannek J; Subong E N; Jones K A; Marschke P L; Epstein J I; Chan D W; Carter H B; Luderer A A; Partin A W
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer.
Urology 1996;48(6A Suppl):51-4.
1996: Taylor D C; Bhagavan B S; Larsen M P; Cox J A; Epstein J I
Papillary urothelial hyperplasia. A precursor to papillary neoplasms.
The American journal of surgical pathology 1996;20(12):1481-8.
1996: Epstein J I
Incidence and significance of positive margins in radical prostatectomy specimens.
The Urologic clinics of North America 1996;23(4):651-63.
1996: Veltri R W; Miller M C; Partin A W; Coffey D S; Epstein J I
Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei.
Urology 1996;48(5):685-91.
1996: Tran K P; Epstein J I
Mucinous adenocarcinoma of urinary bladder type arising from the prostatic urethra. Distinction from mucinous adenocarcinoma of the prostate.
The American journal of surgical pathology 1996;20(11):1346-50.
1996: Steiner G; Cairns P; Polascik T J; Marshall F F; Epstein J I; Sidransky D; Schoenberg M
High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2.
Cancer research 1996;56(21):5044-6.
1996: Doehring C B; Sanda M G; Partin A W; Sauvageot J; Juo H; Beaty T H; Epstein J I; Hill G; Walsh P C
Histopathologic characterization of hereditary benign prostatic hyperplasia.
Urology 1996;48(4):650-3.
1996: Epstein J I
Can insignificant prostate cancer be predicted preoperatively in men with stage T1 disease?
Seminars in urologic oncology 1996;14(3):165-73.
1996: Brooks J D; Bova G S; Ewing C M; Piantadosi S; Carter B S; Robinson J C; Epstein J I; Isaacs W B
An uncertain role for p53 gene alterations in human prostate cancers.
Cancer research 1996;56(16):3814-22.
1996: Smith R C; Partin A W; Epstein J I; Brendler C B
Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation.
The Journal of urology 1996;156(2 Pt 1):454-7; discussion 457-8.
1996: Weinstein M H; Partin A W; Veltri R W; Epstein J I
Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy.
Human pathology 1996;27(7):683-7.
1996: McEntee M F; Epstein J I; Syring R; Tierney L A; Strandberg J D
Characterization of prostatic basal cell hyperplasia and neoplasia in aged macaques: comparative pathology in human and nonhuman primates.
The Prostate 1996;29(1):51-9.
1996: Cher M L; Bova G S; Moore D H; Small E J; Carroll P R; Pin S S; Epstein J I; Isaacs W B; Jensen R H
Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cancer research 1996;56(13):3091-102.
1996: Algaba F; Epstein J I; Aldape H C; Farrow G M; Lopez-Beltran A; Maksem J; Orozco R E; Pacelli A; Pisansky T M; Trias I
Assessment of prostate carcinoma in core needle biopsy--definition of minimal criteria for the diagnosis of cancer in biopsy material.
Cancer 1996;78(2):376-81.
1996: Epstein J I
The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens.
Cancer 1996;78(2):350-6.
1996: Epstein J I; Walsh P C; Sanfilippo F
Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy.
The American journal of surgical pathology 1996;20(7):851-7.
1996: Krajewska M; Krajewski S; Epstein J I; Shabaik A; Sauvageot J; Song K; Kitada S; Reed J C
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
The American journal of pathology 1996;148(5):1567-76.
1996: Epstein J I
Pathologic evaluation of prostatic carcinoma: critical information for the oncologist.
Oncology (Williston Park, N.Y.) 1996;10(4):527-34; discussion 539, 541-3.
1996: Schoenberg M P; Carter H B; Epstein J I
Ureteral frozen section analysis during cystectomy: a reassessment.
The Journal of urology 1996;155(4):1218-20.
1996: Polascik T J; Cairns P; Epstein J I; Fuzesi L; Ro J Y; Marshall F F; Sidransky D; Schoenberg M
Distal nephron renal tumors: microsatellite allelotype.
Cancer research 1996;56(8):1892-5.
1996: Nelson R S; Epstein J I
Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma.
The American journal of surgical pathology 1996;20(4):419-26.
1996: Epstein J I; Partin A W; Sauvageot J; Walsh P C
Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up.
The American journal of surgical pathology 1996;20(3):286-92.
1996: Brown C; Sauvageot J; Kahane H; Epstein J I
Cell proliferation and apoptosis in prostate cancer--correlation with pathologic stage?
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1996;9(3):205-9.
1996: Furuya Y; Krajewski S; Epstein J I; Reed J C; Isaacs J T
Expression of bcl-2 and the progression of human and rodent prostatic cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):389-98.
1995: Gaudin P B; Wheeler T M; Epstein J I
Verumontanum mucosal gland hyperplasia in prostatic needle biopsy specimens. A mimic of low grade prostatic adenocarcinoma.
American journal of clinical pathology 1995;104(6):620-6.
1995: Rosin M P; Cairns P; Epstein J I; Schoenberg M P; Sidransky D
Partial allelotype of carcinoma in situ of the human bladder.
Cancer research 1995;55(22):5213-6.
1995: Polascik T J; Meng M V; Epstein J I; Marshall F F
Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients.
The Journal of urology 1995;154(5):1676-80.
1995: Epstein J I
Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to carcinoma.
Pathology, research and practice 1995;191(9):888-98.
1995: Algaba F; Epstein J I; Fabus G; Helpap B; Nagle R B; Polito M
Working standards in prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
Pathology, research and practice 1995;191(9):836-7.
1995: Epstein J I; Grignon D J; Humphrey P A; McNeal J E; Sesterhenn I A; Troncoso P; Wheeler T M
Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia.
The American journal of surgical pathology 1995;19(8):873-86.
1995: Gaudin P B; Epstein J I
Adenosis of the prostate. Histologic features in needle biopsy specimens.
The American journal of surgical pathology 1995;19(7):737-47.
1995: Kahane H; Sharp J W; Shuman G B; Dasilva G; Epstein J I
Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory.
Urology 1995;45(6):981-6.
1995: Berges R R; Vukanovic J; Epstein J I; CarMichel M; Cisek L; Johnson D E; Veltri R W; Walsh P C; Isaacs J T
Implication of cell kinetic changes during the progression of human prostatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(5):473-80.
1995: Partin A W; Piantadosi S; Sanda M G; Epstein J I; Marshall F F; Mohler J L; Brendler C B; Walsh P C; Simons J W
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.
Urology 1995;45(5):831-8.
1995: Cadeddu J A; Pearson J D; Lee B R; Landis P; Partin A W; Epstein J I; Carter H B
Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.
Urology 1995;45(5):795-800.
1995: Epstein J I
Malpractice vs benepractice.
The American journal of surgical pathology 1995;19(4):482; author reply 485-6.
1995: Pressman E K; Zeidman S M; Reddy U M; Epstein J I; Brem H
Differentiating lymphocytic adenohypophysitis from pituitary adenoma in the peripartum patient.
The Journal of reproductive medicine 1995;40(4):251-9.
1995: Judy K D; Olivi A; Buahin K G; Domb A; Epstein J I; Colvin O M; Brem H
Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Journal of neurosurgery 1995;82(3):481-6.
1995: Bastacky S I; Wojno K J; Walsh P C; Carmichael M J; Epstein J I
Pathological features of hereditary prostate cancer.
The Journal of urology 1995;153(3 Pt 2):987-92.
1995: Carmichael M J; Veltri R W; Partin A W; Miller M C; Walsh P C; Epstein J I
Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
The Journal of urology 1995;153(3 Pt 2):1015-9.
1995: Wojno K J; Epstein J I
The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.
The American journal of surgical pathology 1995;19(3):251-60.
1995: Epstein J I
Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.
Human pathology 1995;26(2):223-9.
1995: Gearhart J P; Lee B R; Partin A W; Epstein J I; Gosling J A
A quantitative histological evaluation of the dilated ureter of childhood. II: Ectopia, posterior urethral valves and the prune belly syndrome.
The Journal of urology 1995;153(1):172-6.
1995: Epstein J I; Carmichael M; Partin A W
OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate.
Urology 1995;45(1):81-6.
1995: Gearhart J P; Willmann J R; Beckwith J B; Epstein J; Partin A W
Nuclear morphometric analysis of metastasis in Wilms' tumor after multimodal therapy: comparison with primary tumor.
Urology 1995;45(1):119-23.
1995: Schoenberg M; Cairns P; Brooks J D; Marshall F F; Epstein J I; Isaacs W B; Sidransky D
Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney.
Genes, chromosomes & cancer 1995;12(1):76-80.
1994: Bastacky S; Silver S A; Epstein J I
Composite cytological smears of pelvic lymph nodes at the time of radical prostatectomy to identify nodal metastases.
Human pathology 1994;25(12):1352-9.
1994: Lee W H; Morton R A; Epstein J I; Brooks J D; Campbell P A; Bova G S; Hsieh W S; Isaacs W B; Nelson W G
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(24):11733-7.
1994: Walsh P C; Partin A W; Epstein J I
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.
The Journal of urology 1994;152(5 Pt 2):1831-6.
1994: Epstein J I; Walsh P C; Brendler C B
Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
The Journal of urology 1994;152(5 Pt 2):1721-9.
1994: Sgrignoli A R; Walsh P C; Steinberg G D; Steiner M S; Epstein J I
Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy.
The Journal of urology 1994;152(4):1077-81.
1994: Epstein J I
Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection.
Seminars in oncology 1994;21(5):527-41.
1994: Epstein J I
Adenosis vs. atypical adenomatous hyperplasia of the prostate.
The American journal of surgical pathology 1994;18(10):1070-1.
1994: Gaudin P B; Epstein J I
Adenosis of the prostate. Histologic features in transurethral resection specimens.
The American journal of surgical pathology 1994;18(9):863-70.
1994: Epstein J I; Carmichael M J; Partin A W; Walsh P C
Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications.
The Journal of urology 1994;151(6):1587-92.
1994: Partin A W; Lee B R; Carmichael M; Walsh P C; Epstein J I
Radical prostatectomy for high grade disease: a reevaluation 1994.
The Journal of urology 1994;151(6):1583-6.
1994: McDowell P R; Fox W M; Epstein J I
Is submission of remaining tissue necessary when incidental carcinoma of the prostate is found on transurethral resection?
Human pathology 1994;25(5):493-7.
1994: Newmark J R; Newmark G M; Epstein J I; Marshall F F
Solitary late recurrence of renal cell carcinoma.
Urology 1994;43(5):725-8.
1994: Partin A W; Pearson J D; Landis P K; Carter H B; Pound C R; Clemens J Q; Epstein J I; Walsh P C
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.
Urology 1994;43(5):649-59.
1994: Sanda M G; Ayyagari S R; Jaffee E M; Epstein J I; Clift S L; Cohen L K; Dranoff G; Pardoll D M; Mulligan R C; Simons J W
Demonstration of a rational strategy for human prostate cancer gene therapy.
The Journal of urology 1994;151(3):622-8.
1994: Partin A W; Yoo J K; Crooks D; Epstein J I; Beckwith J B; Gearhart J P
Prediction of disease-free survival after therapy in Wilms' tumor using nuclear morphometric techniques.
Journal of pediatric surgery 1994;29(3):456-60.
1994: Brem H; Tamargo R J; Olivi A; Pinn M; Weingart J D; Wharam M; Epstein J I
Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
Journal of neurosurgery 1994;80(2):283-90.
1994: Epstein J I; Walsh P C; Carmichael M; Brendler C B
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
JAMA : the journal of the American Medical Association 1994;271(5):368-74.
1994: Schoenberg M P; Hakimi J M; Wang S; Bova G S; Epstein J I; Fischbeck K H; Isaacs W B; Walsh P C; Barrack E R
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer.
Biochemical and biophysical research communications 1994;198(1):74-80.
1994: Murphy G P; Busch C; Abrahamsson P A; Epstein J I; McNeal J E; Miller G J; Mostofi F K; Nagle R B; Nordling S; Parkinson C
Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Scandinavian journal of urology and nephrology. Supplementum 1994;162():7-42; discussion 115-27.
1994: Veltri R W; Partin A W; Epstein J E; Marley G M; Miller C M; Singer D S; Patton K P; Criley S R; Coffey D S
Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression.
Journal of cellular biochemistry. Supplement 1994;19():249-58.
1993: Epstein J I
Discrepancies between findings suspicious for prostate cancer at rectal examination and benign biopsy findings.
Radiology 1993;189(3):657-8.
1993: Epstein J I
PSA and PAP as immunohistochemical markers in prostate cancer.
The Urologic clinics of North America 1993;20(4):757-70.
1993: Partin A W; Pound C R; Clemens J Q; Epstein J I; Walsh P C
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
The Urologic clinics of North America 1993;20(4):713-25.
1993: Cadeddu J A; Pearson J D; Partin A W; Epstein J I; Carter H B
Relationship between changes in prostate-specific antigen and prognosis of prostate cancer.
Urology 1993;42(4):383-9.
1993: Pound C R; Partin A W; Epstein J I; Simons J W; Marshall F F
Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma.
Urology 1993;42(3):243-8.
1993: Bova G S; Carter B S; Bussemakers M J; Emi M; Fujiwara Y; Kyprianou N; Jacobs S C; Robinson J C; Epstein J I; Walsh P C
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Cancer research 1993;53(17):3869-73.
1993: Ronnett B M; Carmichael M J; Carter H B; Epstein J I
Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels?
The Journal of urology 1993;150(2 Pt 1):386-9.
1993: Partin A W; Borland R N; Epstein J I; Brendler C B
Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration.
The Journal of urology 1993;150(1):142-6; discussion 146-8.
1993: Burnett A L; Epstein J I; Gearhart J P
Spectrum of differentiation in pediatric epithelial tumors of kidney: report of two cases.
Urology 1993;42(1):93-8.
1993: Burnett A L; Tillman S L; Chang T S; Epstein J I; Lowenstein C J; Bredt D S; Snyder S H; Walsh P C
Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis.
The Journal of urology 1993;150(1):73-6.
1993: Epstein J I; Carmichael M J; Pizov G; Walsh P C
Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup.
The Journal of urology 1993;150(1):135-41.
1993: Partin A W; Yoo J; Carter H B; Pearson J D; Chan D W; Epstein J I; Walsh P C
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
The Journal of urology 1993;150(1):110-4.
1993: Epstein J I; Carmichael M; Partin A W; Walsh P C
Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
The Journal of urology 1993;149(6):1478-81.
1993: Weinstein M H; Epstein J I
Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy.
Human pathology 1993;24(6):624-9.
1993: Kramer C E; Epstein J I
Nucleoli in low-grade prostate adenocarcinoma and adenosis.
Human pathology 1993;24(6):618-23.
1993: Epstein J I; Pizov G; Walsh P C
Correlation of pathologic findings with progression after radical retropubic prostatectomy.
Cancer 1993;71(11):3582-93.
1993: Epstein J I; Carmichael M; Walsh P C
Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis.
The Journal of urology 1993;149(5):1040-5.
1993: Perlman E J; Epstein J I; Long P P; Pizov G; Griffin C A
Cytogenetic and ploidy analysis of prostatic adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1993;6(3):348-52.
1993: Gikas P W; Del Buono E A; Epstein J I
Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma.
The American journal of surgical pathology 1993;17(5):454-60.
1993: Bastacky S I; Walsh P C; Epstein J I
Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate.
The American journal of surgical pathology 1993;17(4):336-41.
1993: Bova G S; Fox W M; Epstein J I
Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1993;6(2):201-7.
1993: Borland R N; Partin A W; Epstein J I; Brendler C B
The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma.
The Journal of urology 1993;149(2):272-5.
1993: Silver S A; Epstein J I
Adenocarcinoma of the colon simulating primary urinary bladder neoplasia. A report of nine cases.
The American journal of surgical pathology 1993;17(2):171-8.
1993: Partin A W; Getzenberg R H; CarMichael M J; Vindivich D; Yoo J; Epstein J I; Coffey D S
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.
Cancer research 1993;53(4):744-6.
1993: Tamargo R J; Myseros J S; Epstein J I; Yang M B; Chasin M; Brem H
Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.
Cancer research 1993;53(2):329-33.
1993: Partin A W; Gearhart J P; Leonard M P; Leventhal B G; Yoo J K; Crooks D; Epstein J I; Beckwith J B
The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review.
Medical and pediatric oncology 1993;21(3):222-9.
1992: Tardif C P; Partin A W; Qaqish B; Epstein J P; Mohler J L
Comparison of nuclear shape in aspirated and histologic specimens of prostatic carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1992;14(6):474-82.
1992: Epstein J I; Fynheer J
Acidic mucin in the prostate: can it differentiate adenosis from adenocarcinoma?
Human pathology 1992;23(12):1321-5.
1992: Epstein J I; Armas O A
Atypical basal cell hyperplasia of the prostate.
The American journal of surgical pathology 1992;16(12):1205-14.
1992: Lee B R; Partin A W; Epstein J I; Quinlan D M; Gosling J A; Gearhart J P
A quantitative histological analysis of the dilated ureter of childhood.
The Journal of urology 1992;148(5):1482-6.
1992: Rahmouni A; Yang A; Tempany C M; Frenkel T; Epstein J; Walsh P; Leichner P K; Ricci C; Zerhouni E
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography.
Journal of computer assisted tomography 1992;16(6):935-40.
1992: Newmark J R; Hardy D O; Tonb D C; Carter B S; Epstein J I; Isaacs W B; Brown T R; Barrack E R
Androgen receptor gene mutations in human prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(14):6319-23.
1992: Epstein J I; Pizov G; Steinberg G D; Carter H B; Pitcock R; Armas O A; Partin A; Walsh P C
Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.
The Journal of urology 1992;148(1):87-91.
1992: Partin A W; Steinberg G D; Pitcock R V; Wu L; Piantadosi S; Coffey D S; Epstein J I
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.
Cancer 1992;70(1):161-8.
1992: Hall G S; Kramer C E; Epstein J I
Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods.
The American journal of surgical pathology 1992;16(4):315-24.
1992: Gearhart J P; Partin A W; Leventhal B; Beckwith J B; Epstein J I
The use of nuclear morphometry to predict response to therapy in Wilms' tumor.
Cancer 1992;69(3):804-8.
1992: Mohler J L; Partin A W; Epstein J I; Becker R L; Mikel U V; Sesterhenn I A; Mostofi F K; Gleason D F; Sharief Y; Coffey D S
Prediction of prognosis in untreated stage A2 prostatic carcinoma.
Cancer 1992;69(2):511-9.
1992: Partin A W; Carter H B; Epstein J I; Coffey D S
The biology of prostate cancer: new and future directions in predicting tumor behavior.
Monographs in pathology 1992;(34):198-218.
1992: Epstein J I
Controversies in prostate pathology: dysplasia and carcinoma in situ.
Monographs in pathology 1992;(34):149-82.
1992: Epstein J I
Cancer detected incidental to simple prostatectomy (stage A1).
Journal of cellular biochemistry. Supplement 1992;16H():78-82.
1992: Bostwick D G; Montironi R; Nogle R; Pretlow T; Miller G; Wheeler T; Epstein J; Sakr W
Current and proposed biologic markers in prostate cancer.
Journal of cellular biochemistry. Supplement 1992;16H():65-7.
1991: Armas O A; Pizov G; Pitcock R V; Partin A W; Epstein J I
Nuclear morphology of prostatic carcinoma: comparison of computerized image analysis (CAS 200) versus video planimetry (DynaCELL).
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1991;4(6):763-7.
1991: Larsen M P; Carter H B; Epstein J I
Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease.
The Journal of urology 1991;146(4):1059-63.
1991: Tempany C M; Rahmouni A D; Epstein J I; Walsh P C; Zerhouni E A
Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging.
Radiology 1991;181(1):107-12.
1991: Hamper U M; Sheth S; Walsh P C; Holtz P M; Epstein J I
Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions.
Radiology 1991;180(1):101-4.
1991: Wu T C; Mann R B; Epstein J I; MacMahon E; Lee W A; Charache P; Hayward S D; Kurman R J; Hayward G S; Ambinder R F
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens.
The American journal of pathology 1991;138(6):1461-9.
1991: Quinlan D M; Epstein J I; Carter B S; Walsh P C
Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles.
The Journal of urology 1991;145(5):998-1002.
1991: Bastacky S S; Walsh P C; Epstein J I
Needle biopsy associated tumor tracking of adenocarcinoma of the prostate.
The Journal of urology 1991;145(5):1003-7.
1991: Burnett A L; Epstein J I; Marshall F F
Adenocarcinoma of urinary bladder: classification and management.
Urology 1991;37(4):315-21.
1991: Sheth S; Hamper U M; Walsh P C; Holtz P M; Epstein J I
Stage A adenocarcinoma of the prostate: transrectal US and sonographic-pathologic correlation.
Radiology 1991;179(1):35-9.
1991: Christensen W N; Steinberg G; Walsh P C; Epstein J I
Prostatic duct adenocarcinoma. Findings at radical prostatectomy.
Cancer 1991;67(8):2118-24.
1991: Hamper U M; Sheth S; Walsh P C; Holtz P M; Epstein J I
Capsular transgression of prostatic carcinoma: evaluation with transrectal US with pathologic correlation.
Radiology 1991;178(3):791-5.
1991: Carter H B; Brem R F; Tempany C M; Yang A; Epstein J I; Walsh P C; Zerhouni E A
Nonpalpable prostate cancer: detection with MR imaging.
Radiology 1991;178(2):523-5.
1991: Partin A W; Oesterling J E; Epstein J I; Horton R; Walsh P C
Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
The Journal of urology 1991;145(2):405-9.
1991: Epstein J I
The evaluation of radical prostatectomy specimens. Therapeutic and prognostic implications.
Pathology annual 1991;26 Pt 1():159-210.
1990: Steinberg G D; Epstein J I; Piantadosi S; Walsh P C
Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987.
The Journal of urology 1990;144(6):1425-32.
1990: Leonard M P; Partin A W; Epstein J I; Jeffs R D; Gearhart J P
Nuclear morphometry as a prognostic indicator for genitourinary rhabdomyosarcoma: a preliminary investigation.
The Journal of urology 1990;144(5):1222-6.
1990: Carter B S; Epstein J I; Isaacs W B
ras gene mutations in human prostate cancer.
Cancer research 1990;50(21):6830-2.
1990: Hamper U M; Sheth S; Walsh P C; Holtz P M; Epstein J I
Carcinoma of the prostate: value of transrectal sonography in detecting extension into the neurovascular bundle.
AJR. American journal of roentgenology 1990;155(5):1015-9.
1990: Carter B S; Ewing C M; Ward W S; Treiger B F; Aalders T W; Schalken J A; Epstein J I; Isaacs W B
Allelic loss of chromosomes 16q and 10q in human prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(22):8751-5.
1990: Carter H B; Partin A W; Epstein J I; Chan D W; Walsh P C
The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
The Journal of urology 1990;144(5):1167-70; discussion 1170-1.
1990: Epstein J I; Steinberg G D
The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade, volume, and stage of the biopsied and multifocal tumor.
Cancer 1990;66(9):1927-32.
1990: Schlegel P N; Epstein J I; Fishman E K; Brendler C B
Rapidly progressive bilateral ureteral obstruction.
The Journal of urology 1990;144(4):957-60.
1990: Epstein J I; Christensen W N; Steinberg G D; Carter H B
Comparison of DNA ploidy and nuclear size, shape and chromatin irregularity in tissue sections and smears of prostatic carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1990;12(5):352-8.
1990: Oesterling J E; Epstein J I; Brendler C B
Myxoid malignant fibrous histiocytoma of the bladder.
Cancer 1990;66(8):1836-42.
1990: Partin A W; Walsh A C; Epstein J I; Leventhal B G; Gearhart J P
Nuclear morphometry as a predictor of response to therapy in Wilms tumor: a preliminary report.
The Journal of urology 1990;144(4):952-4.
1990: Rifkin M D; Zerhouni E A; Gatsonis C A; Quint L E; Paushter D M; Epstein J I; Hamper U; Walsh P C; McNeil B J
Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.
The New England journal of medicine 1990;323(10):621-6.
1990: Perlman E J; Epstein J I
Blood group antigen expression in dysplasia and adenocarcinoma of the prostate.
The American journal of surgical pathology 1990;14(9):810-8.
1990: Hamper U M; Sheth S; Walsh P C; Epstein J I
Bright echogenic foci in early prostatic carcinoma: sonographic and pathologic correlation.
Radiology 1990;176(2):339-43.
1990: Epstein J I
Evaluation of radical prostatectomy capsular margins of resection. The significance of margins designated as negative, closely approaching, and positive.
The American journal of surgical pathology 1990;14(7):626-32.
1990: Hamper U M; Epstein J I; Sheth S; Walsh P C; Sanders R C
Cystic lesions of the prostate gland. A sonographic--pathologic correlation.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1990;9(7):395-402.
1990: Leonard M P; Canning D A; Epstein J I; Gearhart J P; Jeffs R D
Local tissue reaction to the subureteral injection of glutaraldehyde cross-linked bovine collagen in humans.
The Journal of urology 1990;143(6):1209-12.
1990: Quinn B D; Cho K R; Epstein J I
Relationship of severe dysplasia to stage B adenocarcinoma of the prostate.
Cancer 1990;65(10):2328-37.
1990: Epstein J I; Cho K R; Quinn B D
Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate.
Cancer 1990;65(10):2321-7.
1990: Oesterling J E; Brendler C B; Burgers J K; Marshall F F; Epstein J I
Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy.
Cancer 1990;65(9):1928-36.
1990: Kronthal A J; Fishman E K; Sanders R C; Epstein J I; Kuhlman J E; Brendler C B
Uterine perforation simulating urachal carcinoma: CT diagnosis.
AJR. American journal of roentgenology 1990;154(4):741-3.
1990: Partin A W; Carter H B; Chan D W; Epstein J I; Oesterling J E; Rock R C; Weber J P; Walsh P C
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
The Journal of urology 1990;143(4):747-52.
1990: Christensen W N; Partin A W; Walsh P C; Epstein J I
Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage.
Cancer 1990;65(4):1021-7.
1990: Epstein J I
Relationship of dysplasia to prostate carcinoma.
Seminars in urology 1990;8(1):2-8.
1990: Larsen M P; Steinberg G D; Brendler C B; Epstein J I
Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and "pseudovascular" invasion in transitional cell carcinoma of bladder with lamina propria invasion.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1990;3(1):83-8.
1990: MacCumber M W; Hoffman P N; Wand G S; Epstein J I; Beschorner W E; Green W R
Ophthalmic involvement in aggressive histiocytosis X.
Ophthalmology 1990;97(1):22-7.
1989: Hruban R H; Bhagavan B S; Epstein J I
Massive retroperitoneal angiomyolipoma. A lesion that may be confused with well-differentiated liposarcoma.
American journal of clinical pathology 1989;92(6):805-8.
1989: Partin A W; Walsh A C; Pitcock R V; Mohler J L; Epstein J I; Coffey D S
A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis.
The Journal of urology 1989;142(5):1254-8.
1989: Carter H B; Hamper U M; Sheth S; Sanders R C; Epstein J I; Walsh P C
Evaluation of transrectal ultrasound in the early detection of prostate cancer.
The Journal of urology 1989;142(4):1008-10.
1989: Ronnett B M; Epstein J I
A case showing sclerosing adenosis and an unusual form of basal cell hyperplasia of the prostate.
The American journal of surgical pathology 1989;13(10):866-72.
1989: Salibi S S; Nauta H J; Brem H; Epstein J I; Cho K R
Lipomeningioma: report of three cases and review of the literature.
Neurosurgery 1989;25(1):122-6.
1989: Mohler J L; Erozan Y S; Walsh P C; Epstein J I
Fine-needle core and aspiration biopsy. A new method for diagnosis of prostatic carcinoma.
Cancer 1989;63(9):1846-55.
1989: Hedrick L; Epstein J I
Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma.
The American journal of surgical pathology 1989;13(5):389-96.
1989: Alexander R B; Maguire M G; Epstein J I; Walsh P C
Pathological stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate.
The Journal of urology 1989;141(4):880-2.
1989: Partin A W; Epstein J I; Cho K R; Gittelsohn A M; Walsh P C
Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.
The Journal of urology 1989;141(2):341-5.
1989: Tamargo R J; Epstein J I; Reinhard C S; Chasin M; Brem H
Brain biocompatibility of a biodegradable, controlled-release polymer in rats.
Journal of biomedical materials research 1989;23(2):253-66.
1989: Cho K R; Woodruff J D; Epstein J I
Leiomyoma of the uterus with multiple extrauterine smooth muscle tumors: a case report suggesting multifocal origin.
Human pathology 1989;20(1):80-3.
1989: Brem H; Kader A; Epstein J I; Tamargo R J; Domb A; Langer R; Leong K W
Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.
Selective cancer therapeutics 1989;5(2):55-65.
1989: Cho K R; Rosenshein N B; Epstein J I
Malignant rhabdoid tumor of the uterus.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1989;8(4):381-7.
1989: Walsh P C; Oesterling J E; Epstein J I; Bruzek D J; Rock R C; Chan D W
The value of prostate-specific antigen in the management of localized prostatic cancer.
Progress in clinical and biological research 1989;303():27-33.
1988: Tamargo R J; Epstein J I; Brem H
Heterotransplantation of malignant human gliomas in neonatal rats.
Journal of neurosurgery 1988;69(6):928-33.
1988: Zinreich S J; Kennedy D W; Malat J; Curtin H D; Epstein J I; Huff L C; Kumar A J; Johns M E; Rosenbaum A E
Fungal sinusitis: diagnosis with CT and MR imaging.
Radiology 1988;169(2):439-44.
1988: Epstein J I; Oesterling J E; Walsh P C
Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer.
The Journal of urology 1988;139(5):980-4.
1988: Epstein J I; Oesterling J E; Walsh P C
The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer.
The Journal of urology 1988;139(5):975-9.
1988: Mohler J L; Partin A W; Epstein J I; Lohr W D; Coffey D S
Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections.
The Journal of urology 1988;139(5):1085-90.
1988: Oesterling J E; Chan D W; Epstein J I; Kimball A W; Bruzek D J; Rock R C; Brendler C B; Walsh P C
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
The Journal of urology 1988;139(4):766-72.
1988: Robey S S; Olson J L; Brem H; Epstein J I
Posterior fossa neuroblastoma occurring in an elderly man.
Human pathology 1988;19(3):365-7.
1988: Shurbaji M S; Epstein J I
Testicular vasculitis: implications for systemic disease.
Human pathology 1988;19(2):186-9.
1988: Gardner W A; Coffey D; Karr J P; Chiarodo A; Epstein J; McNeal J E; Miller G
A uniform histopathologic grading system for prostate cancer. Subcommittee on Diagnostic Nomenclature, Prostate Cancer Working Group, Organ Systems Program.
Human pathology 1988;19(1):119-20.
1988: Cho K R; Olson J L; Epstein J I
Primitive rhabdomyosarcoma presenting with diffuse bone marrow involvement: an immunohistochemical and ultrastructural study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1988;1(1):23-8.
1988: Burnett A L; Epstein J I; Marshall F F
Radical cystectomy for transitional cell carcinoma of the bladder. Long-term survival in high risk patients.
European urology 1988;15(3-4):171-5.
1987: Gardner W A; Coffey D; Karr J P; Chiarodo A; Epstein J; McNeal J E; Miller G
Diagnostic nomenclature for prostate cancer.
The Journal of urology 1987;138(6):1436.
1987: Gardner W A; Coffey D; Karr J P; Chiarodo A; Epstein J; McNeal J E; Miller G
Prostatic cancer nomenclature.
Urology 1987;30(4):404.
1987: Walsh P C; Epstein J I; Lowe F C
Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle.
The Journal of urology 1987;138(4):823-7.
1987: Gardner W A; Coffey D; Karr J P; Chiarodo A; Epstein J; McNeal J E; Miller G
Nomenclature of prostatic carcinoma.
Archives of pathology & laboratory medicine 1987;111(10):898.
1987: Oesterling J E; Brendler C B; Epstein J I; Kimball A W; Walsh P C
Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
The Journal of urology 1987;138(1):92-8.
1987: Oesterling J E; Epstein J I; Walsh P C
Long-term autopsy findings following radical prostatectomy.
Urology 1987;29(6):584-8.
1987: Cho K R; Epstein J I
Metastatic prostatic carcinoma to supradiaphragmatic lymph nodes. A clinicopathologic and immunohistochemical study.
The American journal of surgical pathology 1987;11(6):457-63.
1987: Cafferty L L; Epstein J I
Primary liposarcoma of the right atrium.
Human pathology 1987;18(4):408-10.
1987: Oesterling J E; Epstein J I; Gearhart J P
Transitional cell carcinoma of the bladder in an adolescent with Turner's syndrome.
The Journal of urology 1987;137(3):398-400.
1986: Epstein J I; Oesterling J E; Eggleston J C; Walsh P C
Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens.
The Journal of urology 1986;136(6):1234-7.
1986: Oesterling J E; Epstein J I; Walsh P C
The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism.
The Journal of urology 1986;136(5):1030-4.
1986: Epstein J I; Ambinder R F; Kuhajda F P; Pearlman S H; Reuter V E; Mann R B
Localized herpes simplex lymphadenitis.
American journal of clinical pathology 1986;86(4):444-8.
1986: Epstein J I; Paull G; Eggleston J C; Walsh P C
Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup.
The Journal of urology 1986;136(4):837-9.
1986: Epstein J I; Kuhajda F P; Lieberman P H
Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.
Human pathology 1986;17(9):939-42.
1986: Christensen W N; Long D M; Epstein J I
Cerebellopontine angle lipoma.
Human pathology 1986;17(7):739-43.
1986: Epstein J I; Budin R E
Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma.
Human pathology 1986;17(5):514-9.
1986: Epstein J I; Woodruff J M
Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
Cancer 1986;57(1):111-9.
1986: Maria B L; Cafferty L L; Singer H S; Epstein J I; Carson B S
Diffuse leptomeningeal seeding from a malignant spinal cord astrocytoma in a child with neurofibromatosis.
Journal of neuro-oncology 1986;4(2):159-63.
1986: Zinreich S J; Wang H; Epstein J I; Kim W S; Brem H; Anderson J H; Ahn H S; Rosenbaum A E
Carotid bifurcation imaging model for more accurately comparing imaging techniques.
Acta radiologica. Supplementum 1986;369():24-8.
1985: Epstein J I; Lieberman P H
Mucinous adenocarcinoma of the prostate gland.
The American journal of surgical pathology 1985;9(4):299-308.
1984: Epstein J I; Erlandson R A; Rosen P P
Nodal blue nevi. A study of three cases.
The American journal of surgical pathology 1984;8(12):907-15.
1984: Epstein J I; Berry S J; Eggleston J C
Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer.
Cancer 1984;54(8):1666-71.
1984: Epstein J I; Mendelsohn G
Squamous carcinoma of the foot arising in association with long-standing verrucous hyperplasia in a patient with congenital lymphedema.
Cancer 1984;54(5):943-7.
1984: Epstein J I; Hutchins G M
Granulomatous prostatitis: distinction among allergic, nonspecific, and post-transurethral resection lesions.
Human pathology 1984;15(9):818-25.
1984: Epstein J I; Eggleston J C
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Human pathology 1984;15(9):853-9.
1984: Epstein J I; White C L; Mendelsohn G
Factor VIII related antigen and glial fibrillary acidic protein immunoreactivity in the differential diagnosis of central nervous system hemangioblastomas.
American journal of clinical pathology 1984;81(3):285-92.
1984: Epstein J I; Sears D L; Tucker R S; Eagan J W
Carcinoma of the esophagus with adenoid cystic differentiation.
Cancer 1984;53(5):1131-6.
1983: Epstein J I; Hutchins G M
Subepicardial aneurysms: a rare complication of myocardial infarction.
The American journal of medicine 1983;75(4):639-44.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jonathan Epstein

Research Profile (preview)

Disorders

Procedures

Anatomy

Chemicals & Drugs

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jonathan Epstein (preview)

All Publications